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Abstract 
From Source to Tap - A Case Study of Organic Contaminants in Raw and Drink-
ing Water in the Region of Uppsala, Sweden 
Philipp Klöckner 
 
In this study, water samples from the surroundings of Uppsala were examined for 
residues of pesticides, pharmaceuticals and other contaminants characteristic for 
human fecal contamination. The aim was to perform a screening of water samples 
to investigate the level of pollution with the mentioned compound groups. Sam-
ples were taken from upstream and downstream river water, lake water, a drinking 
water treatment plant and treated drinking water. The contaminants were extracted 
from water samples with two different solid phase extraction (SPE) cartridges. 
Identification and quantification was achieved via separation with ultra-
performance liquid chromatography (UPLC) followed by positive and negative 
electrospray ionization (ESI) coupled to a high-resolution time-of-flight (TOF) 
mass spectrometer. Out of 17 analyzed contaminants, 9 could be detected in envi-
ronmental samples of which 5 were detected in finished drinking water. None of 
the targeted pesticides were found in environmental samples or drinking water. 
The average method recovery was 51% and 39% depending on the extraction 
method. The limit of quantification (LOQ) ranged from 0.07 ng L-1 up to 74 ng L-
1. Contaminant concentrations in environmental samples ranged from 0.55 ng L-1 
to 40 ng L-1 and in drinking water from 0.22 ng L-1 to 8.0 ng L-1. Compounds de-
tected were atenolol, benzoylecgonine, bezafibrate, caffeine, carbamazepine, co-
tinine, diclofenac, metoprolol and nicotine. Compounds not detected were atra-
zine, cyanazine, isoproturon, ketoprofen, monensin, quinmerac and simazine. The 
results show that several of the target analytes were present in the environment and 
in drinking water at low but measurable concentrations, which shows that the 
drinking water treatment plant is not able to successfully remove the contaminants 
with conventional treatment techniques. A pilot plant with membrane technology 
is ineffective as well, except when coupled to granular activated carbon (GAC). 
Risk quotients were determined and revealed that no hazards for human health or 
aquatic organisms can be expected from the detected contaminant concentrations. 
 
Keywords: LC-MS, SPE, PPCP, pharmaceuticals, pesticides, surface water, 
screening, Sweden, water contamination, water quality 
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Popular science summary 
 
From Source to Tap - A Case Study of Organic Contaminants in Raw and Drink-
ing Water in the Region of Uppsala, Sweden 
 
Philipp Klöckner 
 
 
In environmental research, many studies have been conducted detecting synthetic 
organic compounds from various origins in rivers, lakes, groundwater and even 
drinking water. Among these contaminants, pharmaceuticals and pesticides play a 
large role as well as indicators of human impact (substances that are excreted with 
urine and feces, for example the decomposition product of nicotine). These com-
pounds have in common that they have a specific mode of action on defined or-
ganisms. Their presence in the environment is of concern since effects on plants, 
animals, microorganisms and humans cannot be excluded. In this study, water 
samples were analyzed for a spectrum of contaminants, consisting of selected 
pharmaceuticals, pesticides and compounds such as caffeine and nicotine. The 
target contaminants were extracted from the water samples with solid phase ex-
traction cartridges, a method that allows removing the compounds from the water 
samples and concentrating them for further analysis. After being concentrated, the 
analytes were separated with the help of liquid chromatography and analyzed by 
using a time-of-flight mass spectrometer. The results of the analyses showed that 
out of the 17 targeted compounds, 9 could be found at different concentration lev-
els in surface water samples. 5 of the compounds present in environmental sam-
ples were detected in treated drinking water. The concentrations found in envi-
ronmental samples ranged from 0.55 ng L-1 to 40 ng L-1 and in drinking water 
from 0.22 ng L-1 to 8.0 ng L-1, which shows that the drinking water treatment plant 
is not able to successfully remove the contaminants with conventional treatment 
techniques. New technologies are being tested for their removal efficiency con-
cerning pharmaceuticals and pesticides. However, in the case of the studied treat-
ment plant, a nanofiltration treatment step was not effectively removing the target 
contaminants. Only when coupled to a carbon treatment, contaminants were suc-
cessfully removed from the water. In order to estimate the hazards of the detected 
concentrations and their impact on aquatic life or humans, risk quotients were 
calculated. None of the detected compounds is present at levels where an effect on 
organisms can be expected.  
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1 Introduction 
Organic compounds occur naturally in water as for example from natural organic 
matter (NOM); however, xenobiotics found their way into natural water bodies. 
These synthetic organic compounds (SOC) can pose serious threats to humans and 
the environment. Knowledge is needed in order to estimate possible risks from 
organic contaminants in water resources. Furthermore, the SOC’s interaction with 
sediments, with other organic compounds or during various treatment steps is of 
high relevance since complexing reactions, adsorption mechanisms and conversion 
processes have a strong impact on the treatment efficiency at various treatment 
steps in drinking water treatment plants and influence the choice of treatment solu-
tions (Ivančev-Tumbas, 2014). The fact that contaminants can undergo physico-
chemical and biological transformations in the environment with unsure outcome 
increase the complexity of the topic.  
 
Major groups of xenobiotics in aquatic bodies include pesticides, pharmaceuticals 
and personal care products. These compounds have different chemical properties, 
yet they have in common that they are able to exert specific effects in organisms 
(Daughton and Ternes, 1999; Halling-Sørensen et al., 1998). In order to estimate 
possible hazards, it is therefore important to know at what concentrations which 
contaminants are present in aquatic bodies. 
 
Improvements in molecular analysis have made the detection of many compounds 
even at ng L-1 level possible (Ivančev-Tumbas, 2014). Among the methods of mo-
lecular analysis, liquid chromatography (LC) coupled to high-resolution mass 
spectrometry (HRMS) is the most common. A widely used method to extract ana-
lytes from water samples prior to analysis is solid phase extraction (SPE) 
(Richardson and Ternes, 2014). Within the last decades, studies were conducted 
all over the world and revealed water contamination with pesticides, pharmaceuti-
cals and personal care products at levels from few ng L-1 up to several µg L-1.  
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2 Objectives and hypotheses 
2.1 Objectives 
This study aims to provide a screening of water from the Uppsala region for the 
occurrence and concentrations of a spectrum of organic contaminants. 
 
Within this study, several river, lake and drinking water samples were taken and 
analyzed for a range of organic compounds. The largest fraction of these com-
pounds consists of human and veterinary pharmaceuticals and pesticides. Further-
more, metabolites of caffeine, nicotine and cocaine were analyzed, since they can 
be used as indicators of fecal contamination or for the estimation of consumption 
patterns (Daneshvar et al., 2012; van der Aa et al., 2013). The study ranges "from 
source to tap" in order to consider the fate of contaminants in different water bod-
ies.  
2.2 Hypotheses 
• River water (downstream the wastewater treatment plant) will show highest 
concentrations of contaminants, followed by lake water; drinking water will 
have the lowest contaminant concentrations. 
• The drinking water treatment techniques sand filter, GAC, chloramination and 
nanofiltration are not able to remove all contaminants. 
• No risks for humans result from the presence of the studied organic contami-
nants in drinking water. 
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3 Background 
 
3.1 Pharmaceuticals 
Pharmaceuticals are not completely transformed in the body but excreted in large 
amounts unchanged or slightly transformed (Heberer, 2002). Their persistency 
inhibits a removal during wastewater treatment or degradation in the environment 
(Daughton and Ternes, 1999; Ternes, 1998). Through the effluents of wastewater 
treatment plants, they are released into the aquatic environment (Heberer, 2002). 
In some cases, untreated waste water enters the aquatic system, e.g. by discharge 
without treatment or during storm events from flood overload (Daughton and 
Ternes, 1999). Pharmaceutically active compounds can furthermore enter ground-
water bodies via leachate from landfills or from manufacturing sites (Heberer, 
2002). Another possible contamination pathway is the use of veterinary drugs in 
livestock breeding, e.g. fish farms and poultry (Heberer, 2002; Richardson and 
Ternes, 2014). Pharmaceuticals in the aquatic environment were first detected in 
the beginning of the 1980s (Ternes, 1998; Watts et al., 1984). The attention to-
wards exposure of pharmaceuticals in natural environments grew rapidly in the 
mid 90s (Halling-Sørensen et al., 1998). Throughout the last 10-20 years, pharma-
ceutically active compounds have been found in aquatic environments all over the 
world and are gaining more and more attention as an upcoming main topic in envi-
ronmental chemistry (Daughton and Ternes, 1999; Halling-Sørensen et al., 1998; 
Heberer, 2002; Heberer and Stan, 1997). Pharmaceutically active compounds have 
also been detected in treated drinking water and tap water (Daughton and Ternes, 
1999; Delgado et al., 2012; Heberer and Stan, 1997; Mons et al., 2013).  
 
Pharmaceuticals are designed to have profound effects in the physiology of an 
organism, i.e. they have a determined mode of action. Their biological effect is 
their most important characteristic (Daughton and Ternes, 1999; Halling-Sørensen 
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et al., 1998). What is particularly problematic is that for the desired medical effect, 
pharmaceuticals have properties that are of high importance for their fate in the 
environment. For example their ability to pass lipid membranes, their persistency 
and their lipophilicity are needed for their efficacy in medical treatment but are 
causing problems in the environment (Halling-Sørensen et al., 1998). It is estimat-
ed that up to 3000 different substances are available for medical treatment, of 
which only a small part has been examined for their environmental occurrence and 
effects. Among these drugs are painkillers, antibiotics, antidiabetics, betablockers, 
contraceptors, lipid regulators, antidepressants and impotence drugs (Richardson 
and Ternes, 2014). Although many pharmaceuticals are responsible for acute or 
chronic effects in aquatic organisms, the concentrations that are typically observed 
in water samples are below the lowest observed effect concentrations (LOEC). 
Some are however occurring at alarmingly high levels, for example diclofenac, 
ciprofloxacin or propanolol (Richardson and Ternes, 2014).  
 
3.2 Pesticides 
Pesticides are used in agricultural production to protect plants from pests or plant 
diseases and to control weeds. The use of these chemicals led to a strong increase 
in yields and agricultural production (Bolognesi, 2003). The term 'pesticide' de-
scribes a whole range of products, including herbicides, insecticides, fungicides, 
growth regulators, biocides and many more. Pesticides are most commonly used as 
plant protection products (PPPs) in order to protect crops and to influence their life 
processes as well as to prevent the growth of undesired plants. They contain so-
called 'active substances', which are chemicals, plant extracts, pheromones or mi-
cro-organisms that have a certain action against pests or undesired plant products 
(Pesticides - European Commission, 2015). Many of these chemicals show a high 
stability towards degradation and can persist in the environment over several years 
(Bolognesi, 2003). Although pesticides are designed to have an effect only on 
selected organisms, it cannot be excluded that they have toxic effects on others. 
Many pesticides are proven to have toxic effects on humans. Studies about the 
acute toxicity of pesticides have been conducted comparably often; however, the 
fate of these chemicals in the environment and delayed effects are less studied 
(Bolognesi, 2003). Not only local environments are affected but human health is 
threatened when pesticides enter surface water bodies, since the latter are a prima-
ry source of drinking water (Gilliom et al., 1999; Tani et al., 2012).  
 
Pesticides enter surface water and wastewater as runoff from the sites where they 
are applied (Masiá et al., 2013). Among the most important pathways are spray 
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drift, surface runoff, leaching, improper operation of pesticide equipment as well 
as runoff from streets (Gerecke et al., 2002). Residues of pesticides can be found 
in food and drinking water. Exposure to humans is also possible via air 
(Bolognesi, 2003). The use of pesticides and biocides is not restricted to agricul-
tural application; a broad range is used in urban areas as well, for example as pre-
servatives in cosmetics or material protection agents such as in wood (Schoknecht 
et al., 2003; Wittmer et al., 2010). Pesticides that are used in urban areas, for ex-
ample on lawns and streets or in building materials, are easily washed away during 
rain events and can therefore enter WWTPs (Gerecke et al., 2002). Materials that 
contain for example biocidal active ingredients might release them during their 
service life. Among these may be ingredients in carpets, plastic films, preserva-
tives for masonry or coatings and wood preservatives that can be released into the 
air or into the water (Schoknecht et al., 2003).  
 
Many studies focus more on transformation products of pesticides rather than ex-
amining the parent compound. The transformation products can be more toxic than 
the parent compounds and they can appear in much higher concentrations 
(Richardson and Ternes, 2014). This can be particularly problematic when parent 
compounds are below a certain guideline value and are therefore considered safe 
while their transformation products pose severe risks to the aquatic environment. 
Pesticides can be found in many streams and in groundwater almost everywhere 
and the concentration in water is strongly related to the amounts used in the re-
spective area. Therefore, pesticide levels in water vary with the season, since dur-
ing spring and summer more pesticides are applied (Gilliom et al., 1999). They 
also vary with the geographic area, showing the importance of agricultural and 
urban areas. Impacts on aquatic ecosystems and to human health are very likely. 
The occurrence of pesticides in mixtures increases the difficulty of their assess-
ment and might lead to unpredictable toxic effects (Gilliom et al., 1999). Even if 
single pesticides are found in very low concentrations that might be considered 
harmless to aquatic life or human health, the effects resulting from combined ac-
tion in a mixture can be significant (Chèvre et al., 2006). Areas with mixed land 
use and urban areas are considered to be just as important for the contribution with 
pesticides and herbicides as are agricultural areas (Wittmer et al., 2010). Many 
governments regulate pesticide concentrations in drinking water. In EU law for 
example, the maximum concentration of pesticides in drinking water is 0.5 µg L-1 
(Masiá et al., 2013; Tani et al., 2012). Pesticide levels are regulated by the Council 
Directive 98/83/EC which allows a maximum total pesticide concentration of 0.5 
µg L-1 and a maximum concentration for single pesticides of 0.1 µg L-1. The total 
pesticide concentration is defined by the sum of all detected and quantified pesti-
cides (during monitoring). However, it is not indicated in the directive which 
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compounds have to be included in the monitoring procedure. An exemption is 
made for the pesticides aldrin, dieldrin, heptachlor and heptachlor epoxide: for 
these compounds, individual concentrations of only 0.03 µg L-1 are acceptable 
(European Commission, 1998). Admission of new pesticides in the EU is regulat-
ed by the Council Directive 91/414/EEC, which defines the properties compounds 
are required to have in order to be approved for application (Council of the 
European Communities, 1991; EFSA, 2015). About 450 active substances are 
approved by the European commission and are available on the market (EU Pesti-
cides database - European Commission, 2015). The National Primary Drinking 
Water Regulations (NPDWRs) of the USA list specific maximum concentrations 
for individual organic chemicals including some pesticides instead of having gen-
eral values, as in EU law (US EPA, 2014).  
3.3 Other contaminants 
Not only pharmaceuticals and pesticides are in the focus of environmental research 
– personal care products, nanomaterials, synthetic musks, perfluorinated com-
pounds (PFCs), disinfection-by-products (DBPs) and brominated flame retardants 
in water are of high importance as well (Richardson and Ternes, 2014). Some or-
ganic contaminants can have endocrine disrupting effects and have also been 
found in drinking water (Delgado et al., 2012). The term 'emerging contaminants' 
refers to compounds that are only recently detected in the environment in various 
quantities and that could have effects on human health or ecosystems. A database 
has been established and can be accessed online, containing over 1000 emerging 
pollutants in the environment (Emerging substances | NORMAN, 2015). Personal 
care products are often used for the tracking of human fecal contamination 
(Daneshhvar et al., 2012). 
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3.4 Liquid chromatography 
The separation of components in complex mixtures is a crucial step for their iden-
tification and quantification. For many compounds, this is only possible with the 
means of chromatography, a set of methods that allows the separation of closely 
related compounds. Liquid chromatography (LC), in particular, is one of the most 
commonly used separation techniques in chemical analysis. This method is appli-
cable in many fields of science and industries. The possibility of automation, the 
high sensitivity, the accuracy of quantification and its suitability for the separation 
of thermally fragile species are only some of the reasons for its high popularity 
(Skoog et al., 2007). Many studies base on the combination of LC and mass spec-
trometry (MS), allowing the detection of many polar micropollutants in the envi-
ronment, such as pharmaceuticals and pesticides (Krauss et al., 2010). Throughout 
chromatographic separation, the sample that is to be examined is diluted in a mo-
bile phase, which is then forced through a column containing a stationary phase 
(Skoog et al., 2007). In case of liquid-solid chromatography, the mobile phase 
consists of a liquid solvent whereas the stationary phase consists of packed silica 
or artificial polymers containing active sites. Among the active sites, octadecyl 
(C18) chains are the most common; however, phenyl groups, cyano groups, diols 
and octyl (C8) chains are also used (Harris, 2007). During the separation, the 
compounds in the samples are distributed to varying degrees between the station-
ary and the mobile phase. Depending on the properties of the compounds and the 
phases, some components are retained stronger by the stationary phases than oth-
ers. These compounds move more slowly through the column than the compounds 
that are weakly retained by the stationary phase. The time that is needed by a spe-
cific compound to move through the column is referred to as retention time. Due 
to different retention times, compounds exit the column separately and can more 
easily be analyzed and quantified. The most common property after which com-
pounds are separated is polarity (Skoog et al., 2007). 
 
In order to increase the efficiency of LC, the columns are packed with very small 
particles in the size range of 1.7-5 µm. This increases the active area of the sta-
tionary phase and therefore improves the resolution and run time in LC. The 
smaller the particles, the denser the packing in the column, and the higher the re-
sulting backpressure. In high-performance liquid chromatography (HPLC), high 
pressures of up to 150 bar are occurring within the column (Harris, 2007). If one 
solvent or constant solvent mixture in the mobile phase is not sufficiently eluting 
all components in a specific time frame (isocratic elution), gradient elution can be 
used which involves the use of several solvents that differ in strength. In gradient 
elution, the concentration of a solvent B increases over time whereas the concen-
tration of the initial solvent A is reduced likewise. The continuous gradient rapidly 
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elutes all components (Harris, 2007). In reversed-phase chromatography, the pre-
dominant type of chromatography, the stationary phase consists of a nonpolar 
substrate whereas the mobile phase consists of a highly polar solvent such as an 
aqueous solution with various concentrations of polar organic solvents. This leads 
to a faster elution of polar compounds and a slower elution of less polar com-
pounds (see also Figure 1). Reversed-phase methods are capable of separating 
small polar non-ionic species (Skoog et al., 2007). 
 
Figure 1: Polarity and elution in chromatography (after Skoog et al., 2007). 
 
 
3.5 Mass spectrometry  
Mass spectrometry (MS) is a widely used technique for the identification and 
quantification of individual compounds in a sample. It can be used to determine 
the structure of molecules, the elemental composition of a sample, the composition 
of complex mixtures and the occurrence of isotopes. High-resolution MS is a pow-
erful tool for the determination of known and unknown compounds at low concen-
trations in mixtures and is of particular importance in environmental chemistry 
(Krauss et al., 2010; Skoog et al., 2007).  
 
The resolution in mass spectrometry is the inverse of the resolving power. It de-
scribes the smallest mass difference at which separate peaks can be identified 
(Harris, 2007).   
 
9 
 
Depending on the task, different types of mass spectrometers are available, each of 
them having different benefits and limitations (Krauss et al., 2010). Their basic 
functional principles are outlined in chapter 3.5.1 to 3.5.5. 
• Triple quadrupole (QqQ) and quadrupole ion trap (QIT) mass spectrometers 
are the first choice in target analysis due to their high sensitivity. However, their 
ability to detect unknowns is limited (Krauss et al., 2010). 
• Time-of-flight (TOF) technology provides a lower sensitivity; however the 
resolution is much higher than for example in triple quadrupole mass spectrom-
eters (Krauss et al., 2010). 
• The main disadvantage of Fourier transform ion cyclotron resonance (FT-
ICR) mass spectrometers is their high costs, which is why they are rarely used 
(Krauss et al., 2010). 
• Orbitrap technology is getting more and more popular due to the high resolu-
tion, high mass accuracy and very high sensitivity (Krauss et al., 2010). 
 
 
3.5.1 Quadrupole mass analyzers 
The most important element of quadrupole mass analyzers is the 
quadrupole, consisting of four metallic rods that are arranged 
pairwise. These rods serve as electrodes and to each pair, positive 
or negative direct current (dc) is applied (Figure 2). The dc source 
is variable, meaning that the current can be increased over time 
(Skoog et al., 2007). Additionally to the direct current, a stronger 
alternating current (ac) is applied to the rods in a variable frequen-
cy. The ratio between ac and dc voltage is kept constant (slightly 
below 6), even when increasing the voltages during one run 
(Skoog et al., 2007). When an ion enters the quadrupole, the alternating current on 
the rods attracts and repels the ion and thereby influences its trajectory (Figure 3). 
If the ion is heavier or lighter than a target mass, it is diverted and neutralized at 
one of the rods. Only ions with a specific mass-to-charge ratio (m/z) are able to 
oscillate in resonance to the alternating current and to pass the quadrupole on a 
stable trajectory (Gates, 2014a; Harris, 2007; Skoog et al., 2007). 
Figure 2: Positive 
or negative direct 
current (dc) applied 
to the rods. 
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Figure 3: Schematic of a quadrupole. (Gates, 2014a) http://www.chm.bris.ac.uk/ms/images/quad-
schematic.jpg 
The mass-to-charge ratio (m/z) is defined by the ratio of the mass number of an 
ion to the number of charges on the ion. It is often referred to as 'mass' since most 
ions in MS are only charged singly. The quadrupole serves as a mass filter, since 
only ions within a narrow range of m/z values can pass the quadrupole successful-
ly. The detector after the quadrupole recognizes at what current and frequency 
settings ions can pass and is thereby able to detect a whole mass spectrum in short 
time. Very common is the arrangement as a so-called triple quadrupole. In this 
instrument, a first quadrupole filters for mother ions, which are then dissociated in 
a collision cell. The ion fragments are then again separated in a subsequent quad-
rupole. The analysis of fragments allows a more reliable determination of com-
pounds. Triple quadrupole instruments are an example of tandem mass spectrome-
try (Skoog et al., 2007). 
 
3.5.2 Quadrupole ion-trap mass spectrometer 
 Another type of mass spectrometer that can be combined with chromatographic 
instruments is the quadrupole ion-trap mass spectrometer. Ions are inserted into 
the ion trap, a chamber consisting of two end caps (electrodes) and a ring elec-
trode. The ring electrode is supplied with a variable radio-frequency voltage. Ions 
inserted into the chamber can be stored for up to 15 minutes. The radio-frequency 
voltage stabilizes ions in the cavity on a circular trajectory, i.e. ions circulate in the 
ion trap. A change in the electric field results in destabilization of the circular tra-
jectory of ions within a narrow m/z ratio. By increasing the voltage applied to the 
ring electrode, ions leave the trapping field depending on their mass to charge 
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ratio. A detector captures the ejected ions and generates a signal (Harris, 2007; 
March, 2000; Skoog et al., 2007).  
 
3.5.3 Time-of-flight (TOF) mass spectrometer 
As the name describes, the mass of ions in a TOF instrument is calculated by their 
respective time of flight. Compounds are ionized and accelerated by an electric 
field before flying through a drift tube. Since the ions (theoretically) acquire the 
same kinetic energy, ions with a higher mass to charge ratio will arrive later at the 
detector than ions with a lower mass to charge ratio. The time an ion needs to "fly" 
from the ionizing source to the detector is in direct relation to its mass to charge 
ratio (Skoog et al., 2007). However, not all ions acquire the exact same kinetic 
energy, resulting in different times of flight for ions with the same mass. To tackle 
this problem, a reflectron element can be installed in the drift tube. This element 
reflects the ions, reverses their flight direction and improves resolving power 
(Harris, 2007). The reflectron consists of a decelerating field with a growing po-
tential that is used to stop the ions. The time needed for an ion to enter the field 
and to leave it again does not depend on the initial velocity but solely on its mass. 
Like that, differences in kinetic energy can be extinguished and the resolution can 
be improved (Mamyrin, 2001). 
 
3.5.4 Fourier transform ion cyclotron resonance (FTICR) 
Among all broadband mass analysis techniques, FT-ICR provides the highest re-
solving power and mass accuracy. The precision in mass acquisition and the high 
resolution results from a different principle of measurement: instead of separating 
the ions before reaching the detector, masses are determined by measuring a fre-
quency. The heart of the instrument consists of an ion trap analyzing cell in which 
the ions are accelerated by a radio-frequency signal. They are moving on a circular 
trajectory, a cyclotron. The ions are being excited by an electric pulse and acquire 
a frequency that is depending on their mass. This frequency can be measured very 
precisely and with the means of a frequency to mass conversion, the determination 
of the ions mass to charge ratio is possible (Heeren et al., 2004; Shi et al., 2000; 
Skoog et al., 2007).  
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3.5.5 Orbitrap mass spectrometers 
In an orbitrap mass analyzer, static electric fields 
are used rather than dynamic electric fields which 
come to use in a quadrupole ion trap (Hu et al., 
2005). The orbitrap consists of a central electrode 
(cathode) that is aligned coaxially through an 
outer electrode (anode). Both electrodes are sup-
plied with a direct current (dc), creating a purely 
electrostatic field. Ions are entering the ion trap 
perpendicularly to the central electrode (red ar-
row in Figure 4) and start moving on an orbital 
trajectory around the inner electrode. Stabilized 
ions move axially along the inner electrode and 
rotationally around it. This process is called orbital trapping. The detection of ion 
masses works in a way similar to FTICR - an image current of the ions on their 
oscillating trajectory is recorded and goes through a conversion to produce a time-
domain transient (Perry et al., 2008). Because the Orbitrap operates with a pulsed 
ion source, a coupled quadrupole for storage of ions is required in order to use 
continuous electrospray ionization (Hu et al., 2005).  
 
All presented types of mass spectrometers have their advantages and disad-
vantages. However, hybrid instruments, in which a combination of quadrupole and 
TOF technology (QTOF) or a combination of linear ion trap and orbitrap technol-
ogy (LTQ orbitrap) is used, provide excellent detection possibilities in various 
matrices (Kosjek et al., 2007; Krauss et al., 2010; Petrovic and Barceló, 2006). 
The LTQ Orbitrap in particular offers a high dynamic range and excellent sensitiv-
ity (Krauss and Hollender, 2008). In other cases, the use of different technologies 
in various runs is beneficial. For example, the use of a triple quadrupole for a first 
quantification and a separate run in a time-of-flight mass spectrometer for confir-
mation describes an established strategy (Krauss et al., 2010). The use of different 
mass spectrometers combined is referred to as 'tandem mass spectrometry'. 
 
3.6 Ionization techniques in LC: 
• Electrospray ionization (ESI); Electrospray ionization is the most common ioni-
zation technique for LC-MS. It is a comparably soft ionization method but lacks 
the ability to produce fragments. It is considered only successful for compounds 
with at least one N, P, O, S or metal atom whereas compounds containing only 
C, Si, H and halogens are not likely to be ionized by ESI. The analyte is intro-
Figure 4: Cutaway view of the ion trap in an 
Orbitrap; image from (Hu et al., 2005). 
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duced and passed through an electrospray needle, which has a high potential dif-
ference with respect to the receiving cone (the counter electrode). In the space 
between needle tip and cone, the solvent evaporates, causing the small droplets 
from the needle spray to be ripped apart. The ionization results from the charge 
the molecules get due to the high potential difference between needle and cone 
(Gates, 2014b; Hug et al., 2014). 
• Atmospheric-pressure chemical ionization (APCI); APCI shares some similari-
ties with ESI. The analyte is ejected by a spray needle, which has, in contrast to 
ESI, no electric potential. Instead, ionization occurs with the help of a corona 
discharge needle. The electric corona is a plasma containing charged particles. 
After being ejected from the spray needle, the solvent evaporates. Meanwhile, 
the corona discharge needle is put under high voltage and therefore transforms 
surrounding H2O to H3O+. The molecule from the analyte reacts with the H+ 
from H3O+, leaving an ionized molecule [M+H+] and H2O. APCI is in contrast 
to ESI not suitable for thermally labile compounds (Gates, 2014c; Harris, 2007).  
• Matrix-Assisted Laser Desorption/Ionization (MALDI): For the ionization with 
MALDI, a matrix has to be created on a sample plate, isolating the analytes 
from each other. This is referred to as solid solution. Afterwards, a laser beam 
leads to the ejection of analyte and matrix molecules from the sample plate (ma-
trix excitation). Just above the sample plate, proton transfer from the matrix 
molecules to the analytes ionizes analyte molecules. Furthermore, cations can 
attach to the analyte. [M+H]+, [M+Na]+, [M+K]+ ions are formed.  
 
In gas chromatography, different ionization methods are used, such as electron 
ionization (EI) or chemical ionization (CI).  
 
3.7 Analytical approaches in MS 
In general, three different analytical approaches exist.  
• In quantitative target analysis, compounds in the sample are measured and 
their retention time, mass and fragments are compared to a reference stand-
ard. A list of target ions is created before analysis and the analysis focuses on 
finding these defined ions in the sample. If new substances shall be detected, 
the analysis has to be run again with the respective reference standard 
(Krauss et al., 2010). 
• If the reference standards are not available, quantification and confirmation of 
compounds has to be achieved with a different method. In suspect screening 
analysis, a list of suspected ions with known compound-specific information 
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is defined. Molecular formula and structure of the suspected ions can be used 
for the detection of compounds. Theoretically predicted isotope patterns, ex-
act calculated m/z ratios, physico-chemical properties and related expected 
retention times of the suspect ions help in the detection of compounds. The 
possibility of false positive findings and false negatives are reasons for the ra-
re appliance of suspect screening in environmental research (Krauss et al., 
2010). 
• In contrast to target analysis and suspect screening, non-target screening 
aims at detecting compounds of which no information is available or which 
might not be expected in the examined sample. The procedure usually in-
volves the detection of peaks by exact mass filtering after chromatography, 
the deduction of a possible mass formula for the detected peak and the com-
parison of the findings with databases. In that way, various possible com-
pounds can be estimated and ranked according to the possibility of appear-
ance. For final confirmation, the findings can be compared to the measure-
ment of a reference standard. Finding the most probable chemical structure to 
the molecular formula that is derived from the detected peak represents the 
main challenge in non-target screening (Krauss et al., 2010). An overview of 
a possible working procedure for suspect screening and non-target screening 
can be found in (Hug et al., 2014). 
3.8 Solid phase extraction (SPE) 
One of the most important sample preparation methods is solid phase extraction 
(SPE). The first SPE cartridges were introduced in 1978 (Hennion, 1999), and has 
developed tremendously ever since. SPE was introduced as an alternative of liq-
uid-liquid extraction (LLE) and has replaced it successfully. LLE uses large 
amounts of solvents that are costly to dispose of and is more time consuming to 
use. The demand for more environmentally friendly laboratory methods increased 
the popularity of SPE (Hennion, 1999; Poole, 2003).  
 
SPE is based on the partitioning of dissolved compounds between two phases, i.e. 
a liquid phase and a solid phase. The sample itself constitutes the liquid phase; the 
sorbent is the solid phase. When passing a liquid sample through a SPE device, the 
analytes bind to the sorbent. The bound analytes can afterwards be eluted with an 
appropriate solvent (Camel, 2003). One of the strongest advantages is the ability 
of SPE to extract many polar analytes from water samples. A broad range of 
sorbents is available on the market, from cross-linked copolymers over n-
alkylsilica to graphitized carbons and more. Some sorbents have been developed 
especially for the analysis of polar analytes. When SPE is directly coupled to 
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chromatographic analysis (mostly LC), it is referred to as 'on-line' whereas an 
extraction separated from chromatography is called 'off-line' SPE. On-line SPE 
allows automatic operation and is less time consuming. In environmental analysis, 
the extraction of a broad range of compounds with various polarities via SPE and 
the subsequent analysis with LC-MS is a very popular approach, e.g. for the analy-
sis of organic compounds in water samples (Hennion, 1999). 
 
SPE devices exist as cartridge and disks; however, with the basic principle being 
the same, the main difference is the format. Whereas disks are only available from 
industrial manufacturers, cartridges can be prepared in the lab. Disks are much 
more expensive than cartridges but have the advantage of being less prone to clog-
ging and pressure drops within the SPE device than cartridges. Therefore, disks 
allow higher sample flows and shorter sample processing times (Poole, 2003). 
They both are limited with regards to handling samples with suspended solids and 
prior filtration is necessary to avoid clogging. Some manufacturers integrate filters 
into their SPE cartridges (Hennion, 1999). 
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4 Materials and methods 
4.1 Target analytes 
The target analytes included in this study are presented in Table 1. The targeted 
pesticides include herbicides (atrazine, cyanazine, isoproturon, quinmerac, sima-
zine) and an anthelmintic against parasitic worms (albendazole-sulfone). The tar-
geted pharmaceuticals include beta blockers (atenolol, metoprolol), blood lipid 
regulators (bezafibrate), psychoactive drugs (carbamazepine), pain killers (diclo-
fenac, ketoprofen) and veterinary drugs (ketoprofen, monensin). Compounds re-
ferred to as personal care products are commonly used as fecal source indicators. 
Compounds of this group that were included in this study were caffeine, nicotine, 
a metabolite of nicotine (cotinine) and a metabolite of cocaine (benzoylecgonine). 
This range of compounds was already used in previous studies. It is based on us-
age amounts and was established to identify sources of fecal contamination. If 
contamination with fecal matter was found via the identification of E. coli bacte-
ria, the selected range of compounds should help identify from which source the 
contamination came from (e.g a household or a poultry farm). The compounds 
analyzed in this study are part of this range and represent a compromise – only 
compounds that were found to work well with the developed method were used. 
 
Table 1: Properties of the analyzed contaminants; Kow is the octanol-water partitioning coefficient, 
Sw is water solubility. 
Name Type Mass  
[g mol-1](a) 
Molecular  
formula(a) 
log KOW 
(c) 
Sw 
Albendazol-
sulfone 
Pesticide 297.3302 C12H15N3O4S 1.10 1449 mg L-1 (b) 
Atenolol Pharmaceutical 266.33608 C14H22N2O3 -0.03 13300 mg L-1(a) 
Atrazine Pesticide 215.68326 C8H14ClN5 2.82 34.7 mg L-1(a) 
Benzoylecgon-
ine 
Metabolite of 
cocaine 
289.32636 C16H19NO4 -1.32 3820 mg L-1(c) 
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Bezafibrate Pharmaceutical 361.8194 C19H20ClNO4 4.25 1.55 mg L-1 (c) 
Caffeine Beverage ingre-
dient 
194.1906 C8H10N4O2 0.16 21600 mg L-1 (a) 
Carbamaze-
pine 
Pharmaceutical 236.26858 C15H12N2O 2.25 18 mg L-1 (a) 
Cotinine Metabolite of 
nicotine 
176.21508 C10H12N2O 0.34 1*106 mg L-1 (a) 
Cynazine Pesticide 240.6927 C9H13CLN6 2.51 170 mg L-1 (a)  
Diclofenac Pharmaceutical 318.130469 C14H10Cl2NNaO2 4.02 4.47 mg L-1 (c) 
Isoproturon Pesticide 206.28412 C12H18N2O 2.84 72 mg L-1 (d) 
Ketoprofen Pharmaceutical 254.28056 C16H14O3 3.00 51 mg L-1 (a) 
Metoprolol Pharmaceutical 267.3639 C15H25NO3 1.69 1*106 mg L-1 (a) 
Monensin Pharmaceutical 670.87088 C36H62O11 5.43  
Nicotine Tobacco ingredi-
ent 
162.23156 C10H14N2 1.00 1*106 mg L-1 (a) 
Quinmerac Pesticide 221.63972 C11H8ClNO2 2.87  
Simazine Pesticide 201.65668 C7H12ClN5 2.40 6.2 mg L-1 (a) 
a PubChem, b Epi Suite ™, c DrugBank, d WHO, 2003 
(Table 1 continued)  
4.2 Sampling site selection 
Sampling sites were selected according to the natural flow in the aquatic system.  
Sites along river Fyris upstream and downstream of Uppsala were included. 
Furthermore, a lake sample directly after the city (Lake Ekoln) and one at a 
drinking water treatment plant (Lake Görväln) were taken. The distaance between 
the lakes is approximately 50 km. In the treatment plant, samples were taken at 
different treatment steps: from the intake, collecting unfiltered water from a depth 
of 22m; after the sand filter treatment (SF), after the granular activated carbon 
(GAC) and from finished drinking water (DW). The water gets disinfected with 
UV light and chloramine (NH2Cl) before being introduced into the water supply 
system. Furthermore, samples from a pilot plant with nanofiltration technology 
(NF) and GAC were taken. Tap water samples from the treatment plant (DWTP 
DW), school (DW School) and supermarket (DW Supermarket) were taken in 
order to account for possible contamination from within the water supply system. 
The school and supermarket receive the treated drinking water from the described 
DWTP. A map with sampling sites is attached in Appendix A. Figure 5 gives an 
overview of the sampling sites, Figure 6 shows the drinking water treatment plant 
(DWTP) and its treatment steps.  
The carbon in the pilot plant is Norit GAC 1240W, the columns were 2.5 m 
high and filled with 1 m carbon at a width of 9 cm. The flow rate in the pilot plant 
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GAC was 1 L min-1 with a contact time of 6 min. Contact time is the same as in 
full-scale GAC. The nanofiltration module is a Pentair HFc module for capillary 
nanofiltration. 
 
Figure 5: Schematic of sampling points (not to scale); samples were taken from river Fyris before 
(upstream) and after (downstream) passing Uppsala, in Lake Ekoln, Lake Görväln, inside the drink-
ing water treatment plant (DWTP), in a school and in a supermarket. Sampling sites are indicated 
with a red X.  
 
Figure 6: Schematic view of the treatment steps in the DWTP including the pilot plant; raw water 
undergoes treatment by precipitation with aluminium sulfate, sand filtration, GAC and disinfection 
with UV light and chloramine; water in the pilot plant is taken after the sand filtration step of the 
full-scale plant and undergoes nanofiltration and GAC treatment Sampling sites are indicated with a 
red X.  (illustration after Ahrens et al., 2014) 
X 
X 
X X 
X 
X 
X X 
X X 
X 
X X 
X 
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4.3 Sampling 
Samples were taken as grab samples, providing information about the current 
situation at the specific sampling site. A triplicate sample was taken at the site 
Fyris Downstream, while a duplicate was taken from the drinking water at the 
plant (DWTP DW). All other samples were taken onefold. 
The samples from Lake Görväln and within the DWTP were taken on 9th March 
2015. The samples Fyris Upstream, Fyris Downstream and Lake Ekoln were taken 
on 31st March 2015. On April 17th, tap water samples from school and supermarket 
were taken as well as one sample from the pilot plant coupled to GAC, since the 
carbon had been exchanged one week prior to the sampling (Pilot NF + new 
GAC). After sampling, the samples were stored at 5 °C.  
The GAC in the pilot plant was exchanged on 18th of November 2014 and 13th 
of April 2015, i.e. 5 months before the first sampling date and 1 week before the 
third  sampling date. Since the removal efficiency of GAC decreases with its age, 
samples were taken to compare the effect of old and new GAC. 
 
The river samples were taken with a stainless steel bucket and an attached rope. 
The bucket was lowered into the river from a bridge in order to collect samples 
from the middle of the stream. The collected water was then transferred into a 
stainless steel container (Sharpsville containers; Figure 7). Several filled buckets 
were needed to fill one of the steel containers. The sample from Lake Ekoln was 
taken with a stainless steel bucket by walking with waders into the lake from the 
shoreline. The lake sample from Görväln was taken by using an inlet from the 
drinking water  treatment plant (DWTP) that collects water from 5 m depth. This 
was a compromise, since no boat was available to collect water from the lake 
surface and the shoreline would not allow walking in with waders. The sample 
from the 5 m inlet is representative for the surface water, while the intake of the 
treatment plant collects raw water for treatment from a depth of 22 m, using water 
from deeper layers of the lake. The samples in the DWTP Görväln were collected 
directly with stainless steel containers after the various treatment steps. Tap water 
samples were taken in the lunchroom of a local supermarket as well as in the 
kitchen of a primary school. Control samples were taken in the lab from common 
taps as well as from a Millipore station. 
 
Figure 7: Sampling of river water downstream and transfer of sampling water into stainless steel con-
tainers. 
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Samples were taken with stainless steel cans that have a 
volume of ~12 L. (Sharpsville containers). Only 5 L of the 
collected water was used for analysis within this study. The 
containers are usually used by the department to collect 
samples for persistent organic pollutants (POPs) and are 
internally called POP cans. For simplicity, they will therefore 
be referred to as POP cans from now on. Inside the cans, a pipe 
leads to the bottom of the can, allowing pumping out water 
from the can without opening the top lid (Figure 8).  
4.4 Solid phase extraction (SPE) 
Water samples were extracted in the POPs laboratory at the Department of 
Aquatic Sciences and Assessment, Section for Organic Environmental Chemistry 
and Ecotoxicology at SLU, Uppsala. Solid phase extraction (Figure 9) was carried 
out with Waters Oasis HLB (1 g) cartridges and Agilent Bond-Elut ENV (1 g) 
cartridges using a Waters extraction manifold SPE station. The two cartridges 
were used for two reasons: first, the performance of the cartridges should be 
compared; second, the spectrum of compounds that can be extracted with each 
cartridge differs. Before extraction, the cartridges were preconditioned with 
methanol (HPLC grade) by filling the cartridges twice completely and afterwards 
flushing them with Milli-Q water. Water samples were filtered with glass fiber 
filters (Whatman GF/F, 0.7 µm, burned at 400 °C before use) into 5 L glass bottles 
(VWR chemicals) and spiked with 250 µL of a mass-labeled internal standard mix 
prior to extraction (concentration level c = 200 ng mL-1, in methanol). The internal 
standards were taken out of the freezer, acclimatized to room temperature and 
vortexed before being added to the samples in the 5 L glass bottles. The internal 
standard was added to enable future analyses in larger screening studies but were 
not used in this study. A list 
of compounds included in 
the internal standard mix can 
be found in Appendix E. 
SPE usually took place over 
night. For each extraction, a 
batch of 6 bottles were 
connected via tubes to the 
SPE station and a vacuum 
Figure 8: Schematic 
view of a POP can. 
Figure 9: Solid phase extraction (SPE). 
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suction pump sucked the sampling water through the cartridge. Speed was 
adjusted to approximately one drop per second (the loading time was 
approximately 10-15 h). After extraction, the cartridges were washed with 10 mL 
of Milli-Q water and 5 mL of 5% methanol solution before being eluted three 
times with 10 mL of HPLC-grade methanol (Merck KgA) into separate glass 
tubes. The eluate was stored in a freezer at -18 °C. 
4.5 Evaporation 
The eluate was concentrated in a N-Evap 112 Nitrogen Evaporator (Organomation 
Associates Inc.) and pooled afterwards. Glass tubes were rinsed twice with HPLC-
grade Methanol (Merck KgA) when pooling the eluate. The pooled eluate was 
concentrated further to a level of 500 µL before transferring it into a vial (Agilent 
Technologies). Test tubes were rinsed twice with 500 µL HPLC-grade ethanol 
(VWR chemicals). The vials were again concentrated to 500 µL and filled up to 1 
mL with Millipore water. See Figure 10 for a schematic overview of the 
procedure. 
 
Figure 10: Schematic view of eluate concentration. 
 
An overview of chemicals and devices used can be found in Appendix D. 
 
 
4.6 Instrumental analysis: Ultra-performance liquid chromatography and 
high-resolution mass spectrometry 
Chromatographic separation of target compounds was performed with a Waters 
Acquity UPLC H-Class system. Columns used were a Waters HSS-T3-C18  
column (silica skeleton) for positive ion mode and a Waters BEH-C18 column 
(polymer skeleton) for negative ion mode. Run time was 21 minutes. 
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Table 2: Parameters and settings of the LC method. 
Parameter Positive mode Negative mode 
Column type HSS-T3-C18 BEH-C18 
Dimension 2.1 mm x 100 mm 
Particle size 1.8 µm 1.7 µm 
Injection volume 5 µL 
Flow rate 0.5 mL/min 
Column temperature 40 °C 
Mobile phase A consisted of Milli-Q water with 5 mM ammonium formate and 
0.01% formic acid. Mobile phase B consisted of acetontrile and 0.01% formic 
acid. A and B were used for positive ion mode. The mobile phase composition 
gradient for positive mode can be found in Table 3. Solvent concentrations were 
increased and reduced constantly over time according to Table 3. For example 
solvent A had an initial concentration of 95% and decreases linearly from minute 
0.5 to minute 16 while solvent B had an initial concentration of 5% and increases 
steadily to 95% in the same time. 
 
Table 3: Gradient program LC (positive mode). 
Time (min) Solvent A (%) Solvent B (%) 
0.00 95.0 5.0 
0.50 95.0 5.0 
16.00 5.0 95.0 
19.00 1.0 99.0 
19.10 95.0 5.0 
21.00 95.0 5.0 
 
 
Mobile phase C consisted of Milli-Q water with 5 mM ammonium acetate and 
0.01% ammonia. Mobile phase D consisted of acetonitrile and 0.01% ammonia. C 
and D were used for analysis in negative ion mode. The mobile phase composition 
gradient for positive mode can be found in Table 4. See above for an explanation 
of the gradient concentration change.  
 
Table 4: Gradient program LC (negative mode). 
Time (min) Solvent C (%) Solvent D (%) 
0.00 95.0 5.0 
0.50 95.0 5.0 
16.00 5.0 95.0 
19.00 1.0 99.0 
19.10 95.0 5.0 
21.00 95.0 5.0 
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Screening of the water extracts for the target compounds was performed by a time-
of-flight mass spectrometer (Waters Xevo G2-S QTOF) with positive (ESI+) and 
negative (ESI-) electrospray ionization. Target compounds were analyzed in 
resolution mode. The resolution mode is an instrument setting that allows a higher 
mass accuracy (which is needed to differentiate between peaks) while having a 
lower sensitivity during analysis. The data was collected with a MSE method, 
which allows the recording of two acquisition modes (high and low collision 
energy) at the same time. 
 
Table 5: Parameters and settings for the time-of-flight mass spectrometer. 
Parameter Setting 
Capillary voltage (V) positive mode 350 
Capillary voltage (V) negative mode 400 
CID collision energy low (V) 4 
CID collision energy high (V) 10 - 45 
Resolving power (R) at m/z = 556.2766  ~ 30.000 
Mass error during calibration (ppm) < 2 
Cone voltage (V) 30 
Desolvation gas flow rate (L h-1) 700 
Source temperature (°C) 120 
Desolvation temperature (°C) 450 
Collision cell pressure (bar) ~ 2.5 e-5  
Cone gas flow (L h-1) 25 
Mass range (m/z) 100-1200 
Scan time (s) 0.25 
Interval (s) 10 
Acquisition time (min) 0.1 - 19.9 
 
Waters UNIFI Scientific Information System (Version 1.7) was used for 
instrument control, analysis settings, calibration and quantification as well as for 
qualitative analysis. Compound confirmation was done with the help of spiked 
Milli-Q and tap water samples and the detected peaks of the respective compound. 
For data extraction, a mass tolerance of 6 ppm (target match tolerance) and a re-
tention time window of 1 minute were set up. During positive mode, hydrogen, 
sodium and ammonium adducts were searched for. Ionization resulted in [M+H]+ 
[M+Na]+ and [M+NH4]+ ions in positive mode and [M-H]- ions in negative mode. 
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4.7 Quality control 
4.7.1 Preparation of calibration standards 
Calibration solutions were prepared by dilution of standard solutions with Milli-Q 
water for final concentrations of 0, 10, 25, 50, 100 and 150 ng mL-1 (ppb) of the 
respective target compound. A list of the added compounds in the calibration 
solutions can be found in Appendix B.  
 
4.7.2 Lock spray settings 
During the MS runs, a lock mass solution with Leucine Enkephalin (Waters) was 
injected continuously to compensate for a shift in mass determination during 
measurement. In positive mode, lock masses (m/z) were 278.1135 and 556.2766 
and a cone voltage of 30.0 V and a capillary voltage of 300 V was applied. In 
negative mode, the respective masses were 236.1041 and 554.262, while cone 
voltage and capillary voltage where similar.  
 
4.7.3 Extraction efficiency and method recovery 
Extraction efficiency and method recovery were calculated with the help of con-
taminant concentrations in blank and spiked samples of Milli-Q and drinking wa-
ter. The spiked samples were spiked with a mixture of native compounds (same as 
in calibration solutions, see Appendix B) and internal standard mixes. Internal 
standards contain mass-labeled compounds while native compounds are identical 
to the ones found in the environment. The extraction efficiency accounts for the 
method's ability to extract the target compound from a sample, covering adsorp-
tion and elution in the SPE cartridge as well as ionizability and detectability in 
LC-MS. It was calculated with the help of Milli-Q samples that were treated iden-
tically to the environmental samples. Spiking with internal standard and native 
mixes was done before extraction with SPE cartridges. Three replicates were pre-
pared of each blank and spiked sample. The concentration in blank Milli-Q water 
is considered to be background and therefore has to be subtracted. The calculation 
can be seen in Equation 1,  
 Extraction efficiency (%) =  𝐶(𝑀𝑀𝑠𝑠𝑠𝑠𝑠𝑠) − 𝐶(𝑀𝑀𝑏𝑏𝑏𝑏𝑠)
𝑐𝑡ℎ𝑠𝑒𝑒𝑠𝑡𝑠𝑖𝑏𝑏
∗ 100 
Equation 1: Calculation of extraction efficiency. 
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where C(MQ) is the average (n=3) measured concentration of the respective 
compound in spiked or blank Milli-Q water and ctheoretical is the concentration of 
spiked compounds that was added to the sample. 
 
The method recovery accounts not only for the extraction efficiency, but also in-
cludes matrix effects, as for example ion suppression by other compounds than the 
target compound. It can be regarded as a means of how well the method is general-
ly able to detect the targeted compounds. Like the Milli-Q water blanks, drinking 
water blanks and spiked drinking water samples were treated exactly as the envi-
ronmental samples. The blank drinking water sample is again subtracted to ac-
count for background noise. The calculation for the recovery can be found in 
Equation 2, 
 Method recovery (%) =  𝐶(𝐷𝐷𝑠𝑠𝑠𝑠𝑠𝑠) − 𝐶(𝐷𝐷𝑏𝑏𝑏𝑏𝑠)
𝑐𝑡ℎ𝑠𝑒𝑒𝑠𝑡𝑠𝑖𝑏𝑏
∗ 100 
Equation 2: Calculation of method recovery. 
 
where C(DW) is the average (n=3) measured concentration of the respective com-
pound in spiked or blank drinking water and ctheoretical is the concentration of spiked 
compounds that was added to the sample. A summary of extraction efficiencies 
and recoveries, calculated per compound for the two different SPE cartridges can 
be found in Table 6. Extraction efficiencies and recoveries are also shown graph-
ically in Appendix C.  
 
The concentrations measured during instrumental analysis were adjusted with the 
recovery results. That means, if for a specific compound a recovery of for example 
30% was acquired, the detected concentration in the environmental sample was 
recalculated to correct for the low recovery and to calculate the actual amount in 
the sample.  
 
4.7.4 Limit of quantification (LOQ) and limit of detection (LOD) 
The limits of quantification (LOQs) of the described method were calculated with 
the help of response values from spiked drinking water samples. The exact calcu-
lation can be found in Equation 3. LOQ values are presented in chapter 5.1, Table 
6. 
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⎥
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Equation 3: Calculation of the limit of quantification (LOQ). cspiking is the concentration of the target 
compound that was added to the sample; r is the average (n=3) response that was recorded for the 
spiked drinking water samples. 200 is the threshold value for response below which the quantifica-
tion program does not integrate peaks; std.dev is the standard deviation of the measured concentra-
tions in the spiked drinking water samples.  
 
The standard deviations were calculated and added to the limit of quantification in 
order to gain reliability of the calculation. By adding two standard deviations, it 
can be assured that in spiked samples the limit of detection is true for approxi-
mately 97.5% of the samples (see Figure 11).  
 
 
The limit of detection (LOD) in this study is the same as the limit of quantification 
(LOQ), since the instrument type used (QTOF) has a very high resolution and 
quantification precision. While other studies use signal to noise ratios as a means 
to differentiate between the detection and quantification limit, the noise in the 
described method is so low that no reasonable conclusion could be drawn from 
such approach. 
 
Figure 11: Normal curve and standard deviations. 
(http://www.regentsprep.org/regents/math/algtrig/ats2/normal67.gif) 
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5 Results 
 
5.1 Method validation 
As mentioned before, two different SPE cartridges were used for extraction: Wa-
ters Oasis HLB and Agilent Bond-Elut ENV. The average extraction efficiency 
was 97±7% for HLB cartridges and 63±8% for ENV cartridges, while the average 
method recovery was 51±6% for HLB cartridges and 41±4% for ENV cartridges. 
A paired, two-tailed Student t-test was conducted for extraction efficiencies and 
recoveries of HLB and ENV cartridges and revealed that both extraction efficiency 
(p = 0.0067) and recovery (p = 0.0022) were significantly different between the 
two groups, assuming a level of significance of α = 0.05. Therefore it can be con-
cluded that HLB cartridges performed significantly better than ENV cartridges, 
concerning extraction efficiency (53% better extraction efficiency with HLB) and 
recovery (25% better recovery with HLB cartridges). The results of both HLB and 
ENV extractions are presented below; however, since the results conceived from 
the HLB extraction are considered more reliable, the data evaluation and conclu-
sions will be based on only HLB results. Contaminant levels in blank samples 
were <LOQ and are not presented. 
 
The following compounds have not been detected, although the extraction effi-
ciency and recovery would have allowed detection: atrazine, cyanazine, isopro-
turon, ketoprofen, monensin, quinmerac, simazine.  
 
The LOQ of diclofenac was calculated with results from both HLB and ENV car-
tridges, since the automatic peak integration in the Waters UNIFI software did not 
integrate diclofenac peaks in all spiked samples, even though they were clearly 
visible. In the current version of the software, manual peak integration is not pos-
sible. This procedure was an exemption; the calculation of the LOQ with response 
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values from both HLB and ENV extractions was only made for diclofenac. For all 
other compounds, response values of only one extraction method were used. 
 
Table 6: Summary of extraction efficiencies (± standard deviation), recoveries and detection limits 
for HLB and ENV cartridges. 
 HLB ENV   
 Extraction 
efficiency 
Method 
recovery 
LOQ 
[ng L-1] 
Extraction 
efficiency 
Method 
recovery 
LOQ 
[ng L-1] 
Albendazol-
sulfone 
100 ± 17 % 75 ± 9.3 % 0.91 84 ± 12 % 73 ± 5.2 % 0.74 
Atenolol 31 ± 0.77 % 18 ± 1.4 % 0.27 29 ± 1.5 % 21 ± 0.3 % 0.67 
Atrazine 96 ± 5.0 % 36 ± 2.4 % 0.63 76 ± 5.3 % 31 ± 2.0 % 0.71 
Benzoylecgonine 110 ± 6.9 % 71 ± 7.2 % 0.13 77 ± 11 % 64 ± 6.2 % 0.14 
Bezafibrate 120 ± 6.8 % 91 ± 7.4 % 0.67 100 ± 8.0 % 86 ± 4. 0% 0.58 
Caffeine 100 ± 4.5 % 70 ± 8.8 % 3.0 67 ± 7.0 % 50 ± 9.6 % 4.5 
Carbamazepine 110 ± 4.6 % 47 ± 3.6 % 0.16 74 ± 6.3 % 39 ± 2.9 % 0.19 
otinine 100 ± 11 % 86 ± 12 % 0.38 46 ± 12 % 39 ± 5.0 % 0.57 
Cyanazine 96 ± 4.9 % 54 ± 4.7 % 1.0 81 ± 8.6 % 47 ± 5.1 % 1.2 
Diclofenac 84 ± 7.9 % 6.6 ± 3.8 % 74 63 ± 6.3 % 13 ± 7.4 % 74 
Isoproturon 85 ± 4.1 % 31 ± 2.4 % 0.23 73 ± 7.2 % 26 ± 1.2 % 0.25 
Ketoprofen 120 ± 5.7 % 65 ± 6.3 % 4.0 84 ± 6.7 % 52 ± 1.9 % 3.6 
Metoprolol 120 ± 4.8 % 21 ± 2.1 % 0.22 14 ± 19 % 22 ± 2.4 % 0.22 
Monensin 81 ± 5.2 % 67 ± 6.7 % 0.07 69 ± 5.5 % 60 ± 6.5 % 0.08 
Nicotine 14 ± 0.76 % 68 ± 12 % 1.1 31 ± 14 % 33 ± 5.6 % 1.6 
Quinmerac 160 ± 28 % 14 ± 2.0 % 5.6 20 ± 1.8 % 2 ± 0.6 % 28 
Simazine 120 ± 4.5 % 40 ± 2.6 % 1.2 90 ± 13 % 33 ± 2.6 % 1.4 
Average: 97 ± 7 % 51 ± 6 %  63 ± 8 % 41 ± 4 %  
t-test: p-value recovery  0.0067 
0.0022 t-test: p-value extraction efficiency   
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5.2 Concentrations and composition profiles 
The concentrations that were found at each sampling point using either HLB or 
ENV are shown in Figure 12. The error bars show standard deviations for the 
sampling points where more than one sample was taken: at the site downstream of 
Uppsala ("Fyris Downstream"), a triplicate was taken, while the treated drinking 
water in the treatment plant ("DWTP DW") was taken as a duplicate. See chapter 
4.2 for an overview and description of the sample names. The highest total con-
taminant concentration was found at the site Downstream, while the lowest con-
centrations were detected in the water that was filtered by the pilot plant coupled 
to a granular active carbon filter (Nano new GAC). 
 
 
Figure 12: Contaminant concentrations [ng L-1] at all sampling points, results from extraction with 
HLB and ENV cartridges. Samples were analysed onefold except of Fyris Downstream (n = 3) and 
DWTP DW (n = 2). 
All calculated environmental concentrations of both extraction methods are shown 
in Table 7 and Table 8. All findings are presented graphically below, except for 
the concentrations of albendazol-sulfone (0.35 ng L-1 - 1.3 ng L-1). Albendazol-
sulfone was only detected in the samples "Pilot NF + old GAC" and "Pilot NF + 
new GAC", i.e. only in the samples where the nanofiltration technique was 
coupled to a GAC treatment (Table 7). This is further discussed in chapter 6.2. 
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Table 7: HLB concentrations [ng L-1] of all contaminants; values in brackets are < LOQ. 
 LOQ  
[ng L-1] 
 
Fyris 
Upstrea
m 
Fyris 
Down-
stream 
Lake 
Ekoln 
Lake 
Görväl
n 
DWTP 
Intake 
DWTP 
Sand 
Filter 
DWTP 
GAC 
DWTP 
Drinking 
Water 
DW 
School 
DW 
Superma
rket  
Pilot 
NF 
 
Pilot 
NF + 
old 
GAC 
Pilot 
NF + 
new 
GAC 
Albendazole- 
sulfone 
<0.91 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 1.3 (0.35)* 
Atenolol <0.27 26 20 5.2 0.71 <LOQ 0.66 0.58 (0.22)* 0.70 0.86 <LOQ <LOQ <LOQ 
Atrazine <0.63 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Benzoylecgo
nine 
<0.13 <LOQ 0.64 0.55 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 0.06 
Bezafibrate <0.67 <LOQ 1.99 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Caffeine <3.0 32 38 19 <LOQ 6.8 <LOQ 6.5 8.0 7.2 6.9 7.7 4.3 <LOQ 
Carbamazepi
ne 
<0.16 <LOQ 4.65 3.7 3.0 3.0 3.2 2.6 3.2 3.2 3.3 2.8 <LOQ <LOQ 
Cotinine <0.38 2.9 6.0 5.1 4.4 4.1 4.6 4.7 4.6 4.1 4.9 5.0 1.1 <LOQ 
Cyanazine <1.0 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Diclofenac <74 <LOQ (26)* <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Isoproturon <0.23 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Ketoprofen <4.0 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Metoprolol <0.22 1.4 40 15 3.2 3.0 3.7 3.2 1.7 3.5 3.7 1.1 <LOQ <LOQ 
Monensin <0.07 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Nicotine <1.1 4.2 11 3.3 1.2 1.3 1.4 1.4 1.1 (0.48)* (0.64)* 5.6 4.4 <LOQ 
Quinmerac <5.6 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Simazine <1.2 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
*values in brackets are below LOQ; peaks were clearly visible, but the values can-
not be quantified reliably.  
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Table 8: ENV concentrations [ng L-1] of all contaminants; values in bracket are <LOQ. 
 LOQ  
[ng L-1] 
Fyris 
Upstrea
m 
Fyris 
Down-
stream 
Lake 
Ekoln 
Lake 
Görväl
n 
DWTP 
Intake 
DWTP 
Sand 
Filter 
DWTP 
GAC 
DWTP 
Drinki
ng 
Water 
DW 
School 
DW 
Super
market  
Pilot 
NF 
 
Pilot 
NF + 
old 
GAC 
Pilot 
NF + 
new 
GAC 
Albendazole-
sulfone 
<0.74 (0.35)* <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 0.91 0.85 
Atenolol <0.67 24 16 4.1 (0.43)* (0.48)* (0.43)* (0.44)* <LOQ (0.51)* (0.63)* <LOQ <LOQ <LOQ 
Atrazine <0.71 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Benzoylecgo
nine 
<0.14 <LOQ 0.68 0.42 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Bezafibrate <0.58 <LOQ 1.1 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Caffeine <4.5 16 16 9.3 <LOQ (4.3)* <LOQ <LOQ (1.9)* <LOQ <LOQ (3.7)* (2.0)* <LOQ 
Carbamazepi
ne 
<0.19 <LOQ 3.6 3.2 2.5 2.4 2.7 2.6 2.6 2.7 3.1 3.0 <LOQ <LOQ 
Cotinine <0.57 1.9 3.9 3.0 2.5 2.8 2.6 3.2 3.3 3.1 3.4 3.8 0.94 <LOQ 
Cyanazine <1.2 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Diclofenac <74 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Isoproturon <0.25 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Ketoprofen <3.6 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 4.7 
Metoprolol <0.22 0.85 28 10 2.3 2.2 2.2 2.2 0.95 2.5 2.7 6.5 <LOQ <LOQ 
Monensin <0.08 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Nicotine <1.6 5.0 15 3.9 1.9 2.4 1.6 1.7 (0.48)* <LOQ <LOQ 1.7 (1.1)* <LOQ 
Quinmerac <28 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
Simazine <1.4 <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ <LOQ 
*values in brackets are below LOQ; peaks were clearly visible, but the values can-
not be quantified reliably. 
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Nicotine was present in almost every sample (Figure 13). The same is valid for 
cotinine, a metabolite of nicotine (Figure 14). The recoveries (HLB) were 68±12% 
for nicotine and 86±12% for cotinine. Both compounds showed a strong increase 
in concentration between the sampling points upstream and downstream. The 
concentration of both compounds decreased again in samples from lake Ekoln and 
lake Görväln but stayed comparably stable afterwards. Samples from the 
nanofiltration pilot plant (Pilot NF) showed an increase in concentration when 
compared to the intake water. In the samples from the nano pilot plant coupled to 
fresh granular activated carbon (Pilot NF + new GAC), the concentrations 
decreased to <LOQ.  
Figure 13: Nicotine concentration [ng L-1] at all sampling points; values <LOQ were set to zero. 
Figure 14: Cotinine concentration [ng L-1] at all sampling points; values <LOQ were set to zero.  
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Both atenolol (Figure 15) and metoprolol (Figure 16) are active ingredients in 
pharmaceuticals that are prescribed to prevent heart attacks. They belong to the 
group of beta blockers. The recovery (HLB) for atenolol was 18±1.4%, for 
metoprolol 21±2.1%. Atenolol concentrations showed a high standard deviation 
between the triplicate measurements (downstream) and is the only compound with 
a higher concentration upstream than downstream. Both compounds decreased in 
concentration between the sampling points downstream and Lake Görväln and 
remained constantly low throughout the sampling points in Lake Görväln, the 
treatment plant as well as in tap water samples. 
Figure 15: Atenolol concentration [ng L-1] at all sampling points; values <LOQ were set to zero. 
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Figure 16: Metoprolol concentration [ng L-1] at all sampling points; values <LOQ were set to zero. 
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The two pharmaceuticals carbamazepine (Figure 17) and bezafibrate (Figure 18) 
were found in concentrations below 5 ng L-1. The recoveries (HLB) were 47±3.6% 
for carbamazepine and 91±7.4% for bezafibrate. Carbamazepine is used in the 
treatment of epilepsy, shizophrenia, bipolar disorder and neuropathic pain. 
Bezafibrate works as a blood lipid regulator. While bezafibrate was only detected 
at one sampling site (Fyris Downstream), carbamazepine appeared in almost every 
sample. The latter showed a similar concentration pattern as e.g. cotinine: a strong 
increase in concentration at the downstream sampling point was followed by a 
decrease in concentration in the lake samples while staying comparably constant 
throughout the treatment steps, disappearing only in the pilot plant coupled to 
GAC.  
 
Figure 17: Carbamazepine concentration [ng L-1] at all sampling points; values <LOQ were set to 
zero. 
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Figure 18: Bezafibrate concentration [ng L-1] at all sampling points; values <LOQ were set to zero. 
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Neither benzoylecgonine nor caffeine belong to the group of pharmaceuticals or 
pesticides, but still are often included with the PPCP (pharmaceuticals and person-
al care products). Benzoylecgonine (Figure 19) had a recovery (HLB) of 71±7.2% 
while caffeine (Figure 20) had a recovery of 70±8.8%. Benzoylecgonine is a me-
tabolite of the illegal drug cocaine and could only be detected in low concentra-
tions (<1 ng L-1). It was only detected in the downstream river water and the first 
lake sample (Ekoln). Caffeine however was among the compounds of which the 
highest concentrations were detected. Caffeine concentrations reached 38 ng L-1 in 
the downstream river water. The concentration distribution appears to be similar as 
described for cotinine and carbamazepine: increasing in concentration downstream 
of Uppsala, but decreasing again with the lake samples while remaining constant 
throughout different treatment steps in the treatment plant. 
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Figure 20: Benzoylecgonine concentration [ng L-1] at all sampling points; values <LOQ were set to 
zero. 
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Figure 19: Caffeine concentration [ng L-1] at all sampling points; values <LOQ were set to zero. 
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Figure 21 shows a comparison of measured concentrations of different compounds 
in treated drinking water at the treatment plant and the downstream river water. 
Out of 9 compounds that were detected in downstream river water, 6 could still be 
detected in drinking water in concentration up to 8.0 ng L-1 (caffeine). A strong 
difference in concentrations can be seen, when compared to downstream river 
water. 
 
 
A composition profile for the water at all sampling points can be found in Figure 
22. This graph shows the relative composition of each sample, expressed as per-
centage of all contaminants measured. It has to be emphasized that no absolute 
values can be derived from such graphic. Caffeine, metoprolol, nicotine, cotinine 
and carbamazepine were present in most samples and were not removed effective-
ly by the treatment plant. Although their total concentration decreased, the propor-
tions stayed constant. Atenolol had a higher share in the composition upstream of 
Uppsala and became less present throughout later sampling points (compared to 
other compounds). The sample "Pilot NF + new GAC" was the only sample that 
showed a completely different composition than the other samples.  
 
 
Figure 21: Direct comparison between contaminant concentrations downstream and in treated drink-
ing water at the treatment plant. Error bars represent standard deviations of the replicates. 
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Figure 22: Composition profiles of all sampling sites. Atrazine, cyanazine, isoproturon, ketoprofen, monensin, quinmerac and simazine were not detected. 
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5.3 Efficiency of the treatment steps in the drinking water treatment plant 
and the pilot plant 
The drinking water treatment plant was not able to remove all compounds that 
were detected in environmental samples. Even in treated drinking water, some 
compounds were still detected. Figure 23 and Figure 24 show the concentrations 
after different treatment steps, normalized to intake water, which are depending on 
the removal efficiency of the full-scale drinking water treatment plant and the pilot 
plant with membrane technology. The graphs show what fraction of the measured 
concentration in the intake water is present after several filter steps. A value higher 
than 100% would suggest a formation inside the treatment plant. This is unlikely, 
and alternative explanations are discussed later. Neither the full-scale treatment 
plant nor the nanofiltration treatment (without GAC) in the pilot plant was able to 
remove the compounds successfully. Only when coupling nanofiltration treatment 
to new granular activated carbon, compounds were completely removed from the 
water.   
 
Figure 23: Concentrations normalized to intake water in the full scale treatment plant. 
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Figure 24: Concentration normalized to intake water in the pilot plant. 
 
5.4 Risk quotient MEC/PNEC and comparison between common doses 
and daily human intake 
Drinking water is our main food stuff with a consumption of 2.0-2.5 L day-1 for 
adults (including water used for cooking, hot beverages etc.; Westrell et al., 2006). 
In order to estimate whether the detected concentrations pose a risk to humans or 
the environment, risk quotients (RQ) were calculated for the detected compounds. 
The risk quotient is a ratio between the measured environmental concentration 
(MEC) and the predicted no-effect concentration (PNEC), see also Equation 4. 
The PNEC values were derived from literature data. If RQ >1, a potential risk for 
aquatic organisms can be assumed, if RQ <1, the compound is assumed to be 
harmless at the measured concentration.  
 
𝑅𝑀 = 𝑀𝑀𝐶
𝑃𝑃𝑀𝐶
 
Equation 4: Calculation of risk quotients (RQ) with the help of measured environmental concentra-
tions (MEC) and predicted no-effect concentrations (PNEC). 
 
A summary of MEC, PNEC and RQ can be found in Table 9. PNEC values were 
derived from literature data. In previous studies, PNEC values were calculated 
from ecological structure activity relationships (ECOSAR) models (van der Aa et 
al., 2013), calculated from no observable effect concentrations (NOEC) tested with 
aquatic organisms (Komori et al., 2013), estimated from toxicity assays (Deo and 
Halden, 2013) or derived from ecotoxicity tests with crustaceans (Cleuvers, 2005; 
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Savino and Tanabe, 1989; Valcárcel et al., 2011). Values in the present study were 
calculated for drinking water (DW) from the DWTP and downstream river water. 
Drinking water is consumed daily; therefore the risk estimation for drinking water 
is the most relevant to assess. The calculation of downstream water risk quotients 
gives estimates for potential environmental hazards.  
 
Table 9: Predicted no-effect concentrations (PNEC), measured environmental concentrations (MEC) 
and calculated risk quotients (RQ) for detected compounds. PNEC values were derived from litera-
ture data and origin from modelling simulations and toxicity tests. 
 PNEC [ng L
 -1] MEC 
(DWTP DW) 
RQ 
(DWTP 
DW) 
MEC 
(Fyris Down-
stream) 
RQ 
(Fyris Down-
stream) 
Atenolol 310000a <LOQ 0 20 6.4*10-5 
Benzoylecgonine 4900b < LOQ 0 0.64 1.3*10-4 
Bezafibrate 10000c  < LOQ 0 2.0 2.0*10-4 
Caffeine 5200 c  8.0 1.5*10-3 38 7.3*10-3 
Carbamazepine 250 c  3.2 1.3*10-2 4.7 1.9*10-2 
Cotinine 5200 d  4.6 8.8*10-4 6.0 1.2*10-3 
Diclofenac 10000 c  < LOQ 0 26 2.6*10-3 
Metoprolol 7900 a  1.7 2.1*10-4 40 5.1*10-3 
Nicotine 2400 e  1.1 4.5*10-4 11 4.6*10-3 
∑RQ   0.016  0.040 
a Cleuvers, 2005, b van der Aa et al., 2013, c Komori et al., 2013, d Deo and Halden, 2013, eValcárcel 
et al., 2011 
 
Risk quotients varied between 7.1*10-7 and 1.3*10-2 for drinking water and be-
tween 6.4*10-5 and 1.9*10-2 for downstream river water, i.e. they were much lower 
than 1. Even the sum of all risk quotients, ∑RQ, stayed well below 1 (0.016 for 
drinking water, 0.040 for downstream river water). That means, for the detected 
compounds no hazardous effect is assumed. However, it should be noted that these 
calculations neither include all compounds that might be present in the water, nor 
do they include effects of mixture toxicity. Furthermore, the PNEC values were 
derived for aquatic organisms and toxicity to humans can be very different. There-
fore, the uncertainties of the presented risk quotients are high when applied to 
humans. Even if a safety factor of 100 would be applied, the RQ would still be 
below 1 for all compounds except carbamazepine. 
 
An average consumption of two liters tap water per person and day is a conserva-
tive assumption for risk assessment, covering the upper percentiles of the popula-
tion. This value is valid for different countries and people of different sex, age or 
health condition (Westrell et al., 2006). The total amount of contaminant that is 
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taken up within one year, assuming a consumption of two liters tap water per day, 
can be found in Table 10. Even if contaminant concentrations as high as in the 
downstream river water were assumed, the yearly uptake would be far lower than 
common doses.  
 
 
Table 10: Calculated yearly uptake of contaminants assuming a consumption of 2 L drinking water 
per day; n.d.= not detected 
 Drinking water Downstream 
river water 
Common doses 
 Yearly uptake [mg] Yearly uptake [mg]  
Atenolol n.d. 0.015 25 – 100 mg tablets (a) 
Benzoylecgonine n.d. 0.0005 ~ 100 mg cocaine (nasal) (b)   
Bezafibrate n.d. 0.0015 400 mg tablets (a) 
Caffeine 0.0059 0.028 100 mg/cup of coffee (c) 
Carbamazepine 0.0024 0.0034 100 – 400 mg tablets (a) 
Cotinine 0.0034 0.0044 1 mg nicotine per cigarette (d) 
Diclofenac 0.0000 0.019 50 – 100 mg tablets (a) 
Metoprolol 0.0012 0.030 25 – 200 mg tablets (a) 
aDrugbank, bHuestis et al., 2007, cMedlinePlus Medical Encyclopedia, 2015, dBenowitz and Jacob, 
1984 
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6 Discussion 
6.1 Method performance 
In general, method performance was good, even though the recovery showed great 
variations between different compounds. See chapter 4.7.3 for an explanation of 
recovery. Considering the broad range of compounds that were included in the 
method, this is not surprising. While most compounds were recovered well, others 
achieved low recovery rates. Albendazol-sulfone, benzoylecgonine, bezafibrate, 
caffeine and cotinine were recovered at rates above 70%, which can be considered 
high. Values between 40% and 70% can still be considered satisfactory and were 
achieved for carbamazepine, cyanazine, ketoprofen, monensin, nicotine and sima-
zine. Values below 40% were found for atenolol, atrazine, diclofenac, isoproturon, 
metoprolol and quinmerac. At this low level of recovery, quantification of the 
compounds lacks precision, but nonetheless allows detection and rough concentra-
tion estimations (Vieno et al., 2006).  
When comparing recoveries to literature data, mostly values above 75% were 
achieved. For example atenolol: 81-106% (Castiglioni et al., 2005; Vieno et al., 
2006); atrazine: 80-90% (Hildebrandt et al., 2008; Masiá et al., 2013); bezafibrate: 
76% (Castiglioni et al., 2005); caffeine: 78% (Santos et al., 2005), carbamazepine 
89-98% (Castiglioni et al., 2005; Metcalfe et al., 2003a; Santos et al., 2005); diclo-
fenac: 78% (Santos et al., 2005); ketoprofen: 80% (Santos et al., 2005); metopro-
lol: 87-104% (Vieno et al., 2006); simazine: 80-90% (Hildebrandt et al., 2008; 
Masiá et al., 2013). However, these studies focused on specific compounds of the 
same classes whereas the presented work aimed at a broad screening of various 
different compounds. Technically, it is possible to detect the target compounds 
with better recoveries for each individual compound, but for the simultaneous 
detection of the described compounds, it is not possible to perform an optimization 
of the method and the recovery values were therefore considered acceptable. If the 
method was optimized for single compounds, for example by adding clean-up 
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steps or adjusting the pH during chromatography, other compounds could not be 
detected at the same run and multiple samples per site had to be analyzed.   
 
The limit of quantification (LOQ) for most compounds was below 2 ng L-1. Only 
few compounds had higher LOQ values: caffeine, diclofenac, ketoprofen and 
quinmerac. In some cases, the measured concentration in the sample was lower 
than the calculated LOQ. They were presented in brackets in Table 7 but not in-
cluded in the data evaluation. Comparing the calculated LOQ values to LOQs 
from literature data reveals that the presented method was able to detect com-
pounds at comparable levels. Vieno et al.(2006) demonstrated LOQs in drinking 
water of 6.5 ng L-1 for atenolol, 2.2 ng L-1 for metoprolol and 0.2 ng L-1 for car-
bamazepine. Masiá et al. (2013) showed LOQ values of 6.0 ng L-1 for simazine, 
1.0 ng L-1 for isoproturon and 6.0 ng L-1 for atrazine. Another study calculated 
LOQ values of 1.07 ng L-1 for atenolol, 0.1 ng L-1 for bezafibrate, 1.3 ng L-1 for 
carbamazepine (Castiglioni et al., 2005). Generally speaking, the presented LOQ 
values are low, with few exemptions. Caffeine for example had a LOQ of 3.07 ng 
L-1, but since it was detected in most samples at much higher concentrations, the 
higher LOQ is not a problem. The calculation of the LOQ of diclofenac (LOQ = 
74 ng L-1) was problematic, since it was not always detected even in spiked sam-
ples, and the recovery of diclofenac was very low. This is surprising, since it has 
been shown to be well extractable with HLB cartridges (Öllers et al., 2001). 
Quinmerac and monensin had LOQ values of 5.6 ng L-1 and 0.07 ng L-1 and have 
not been detected in any sample, yet a presence at very low concentrations cannot 
be excluded.  
 
For some compounds, the peak identification with the Waters UNIFI software in 
the current version (v1.7) caused problems since it does not allow manual integra-
tion. Therefore, peaks were clearly visible but impossible to quantify. Examples 
are carbamazepine at the sampling site upstream or diclofenac in spiked samples 
and at the site downstream.  
  
Concerning the differences between the two SPE cartridges, it was shown that 
HLB cartridges performed significantly better than ENV cartridges with respect to 
the detected compounds. The method recovery of target analytes was on average 
25% better with HLB cartridges than with ENV. Therefore, the use of just HLB 
cartridges but with several repetitions per sample should be considered for future 
studies. This would increase reliability of the collected data and would allow sta-
tistical analysis including variances.  
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6.2 Comparison of detected concentrations with literature data 
The concentrations detected in the current study are low when compared to data 
from previous studies (see Table 11). Some compounds were within the ranges of 
the data presented in literature (atenolol, carbamazepine, cotinine, metoprolol), 
Others were well below, between 64% to 99% lower than the values presented in 
the literature (benzoylecgonine, bezafibrate, caffeine, diclofenac, nicotine). It can 
be concluded that the contamination of surface waters in the region of Uppsala is 
low for the presented compounds. However, it is important to stress that:  
• other contaminants are likely to be present,  
• degradation of compounds might lead to the creation of more hazardous sec-
ondary molecules,  
• mixture toxicity can lead to unpredictable, toxic effects, and  
• effects on biota in water can be severe due to continuous exposure and cumu-
lative effects as well as multigenerational exposure (Halling-Sørensen et al., 
1998).  
 
 
Table 11: Comparison of detected concentrations with literature data. (n.d. = not detected). 
Compound Fyris Down-
stream 
[ng L-1] 
DWTP DW 
[ng L-1] 
Literature data 
(surface water) 
[ng L-1] 
Reference 
Albendazol-
Sulfone 
n.d. n.d. not available  
Atenolol 20 n.d. 11.8 - 25 Vieno et al., 2006 
Atrazine n.d. n.d. 4.6 - 18.6 Masiá et al., 2013 
Benzoylecgonine 0.64 n.d. 1 - 16 
26.8 
van der Aa et al., 2013 
Baker and Kasprzyk-
Hordern, 2011 
Bezafibrate 2.0 n.d. 350 Ternes, 1998 
Caffeine 38 8.0 105 Kim et al., 2007 
Carbamazepine 47 3.2 1.4 - 66 Vieno et al., 2006 
Cotinine 6.0 4.6 4 - 14 Metcalfe et al., 2003b 
Cyanazine n.d. n.d. 50-810 Rebich et al., 2004 
Diclofenac 26 n.d. 150 Ternes, 1998 
Isoproturon n.d. n.d. 280 (max. conc) Kreuger et al., 2010 
Ketoprofen n.d. n.d. 120 Ternes, 1998 
Metoprolol 40 1.7 3.8 - 116 Vieno et al., 2006 
Monensin n.d. n.d. n.d. - 37 Song et al., 2007 
Nicotine 11 1.1 32.3 Baker and Kasprzyk-
Hordern, 2011 
Quinmerac n.d. n.d. 90 (max. conc.) Kreuger et al., 2010 
Simazine n.d. n.d. n.d. - 48 Masiá et al., 2013 
 
The concentrations of the detected compounds follow the pattern that was ex-
pected. Upstream of Uppsala, 5 compounds were detected in low concentrations, a 
result of effluents from small-scale municipal and private wastewater treatment 
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systems. Although the area surrounding the sampling site is characterized by agri-
culture, no pesticides were found. This is either due to no or low use of the target 
pesticides at the sampling time, a degradation of the pesticides into breakdown 
products, or the successful prevention of pesticide leakage. Furthermore, some 
pesticides like cyanazine and atrazine are banned from the market and not in use 
anymore today. They were included because they could still be found in other 
areas. The sampling took place in spring; therefore some pesticides might be ap-
plied later in the year, at different growing stages and seasons. Downstream of 
Uppsala, shortly after the effluent of the municipal wastewater treatment plant 
enters the stream, a total of 9 contaminants was detected. All of the compounds 
detected in upstream river water were still present. Downstream, concentrations 
were highest for almost all of the detected compounds (only exception: atenolol). 
Pharmaceuticals and personal care products consumed in the city of Uppsala were 
not efficiently removed by the wastewater treatment plant and entered the river 
with the effluent (Daneshvar et al., 2009). Concentrations were expected to de-
crease again at the next sampling point at Lake Ekoln. Here, dilution can be re-
garded as the most important factor. The river water enters the lake and gets dilut-
ed by about 40% in average in the lake water (Nõges et al., 2007). The compounds 
are probably not removed or degraded yet, but rather watered down. In the case of 
benzoylecgonine, the concentration fell below the LOQ. For other compounds, a 
decrease in concentration could be observed. On average, the concentrations were 
reduced by 51% between the site downstream and Lake Ekoln. At the sampling 
point in Lake Görväln, concentrations decreased even more. Compared to Lake 
Ekoln, concentrations in Lake Görväln are reduced by 66% on average. Further 
dilution is one reason for this decrease. However, since the sampling points are 
quite far from each other (~50 km), degradation mechanisms gain importance. 
Phototransformation and biotransformation may lead to the breakdown of the orig-
inal compound into smaller fragments, sorption to particles or sediments can cause 
the retention of contaminants (Daneshvar et al., 2009). Furthermore, it is important 
to mention that the composition profile changed between the sampling location at 
Ekoln and Görväln. The different concentration and composition profile is most 
likely due to the fact that only a smaller fraction of the water at Görväln (about 
25%) comes actually from Lake Ekoln. The other 75% come from other parts of 
Lake Mälaren, the lake to which both Görväln and Ekoln belong to (Wallin et al., 
2000). It is important to mention that the water of Lake Ekoln and at Lake Görväln 
differ with regards to their chemistry. The water of Lake Ekoln has a higher densi-
ty and therefore sinks and accumulates in deeper layers when entering Lake 
(Görväln Köhler, S. 2015). Therefore, the water that is taken up from the DWTP at 
a depth of 22m is likely to be mainly water from Lake Ekoln (Köhler, S. 2015). 
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Within the drinking water treatment plant at Lake Görväln, concentrations re-
mained relatively constant. For some compounds, they even seemed to increase 
(caffeine, cotinine, nicotine). A magnification of pharmaceuticals and personal 
care products within the treatment plant is highly unlikely, the higher concentra-
tions are probably detected due to reduced ion suppression and matrix effects 
(Cullum et al., 2004) since the water is cleaner. In water samples with many ma-
trix compounds, these compete with the target analytes to get a charge during ioni-
zation. The targeted compounds get suppressed by other compounds that are pre-
sent in the sample. As a result, fewer are ionized and therefore not detected in the 
mass spectrometer. When the water is cleaner, more of the suppressing matrix 
compounds have been filtered out and suppression is lower. This makes the detec-
tion of target analytes easier and detected concentrations seem to be higher. This is 
also a possible explanation why albendazole-sulfone was only detected (<LOQ) in 
the samples from the pilot plant combined with GAC treatment, i.e. in the water 
that is expected to be the cleanest of all samples. The pesticide was not found in 
the samples "Intake", "DWTP SF" or "Pilot NF" although the water was going 
through these treatment steps before (see also chapter 4.2, Figure 6). It is highly 
unlikely that the pesticide entered the pilot plant between the nanofiltration step 
and the GAC. However, since the recovery of albendazol-sulfone was high 
(75%±9.3) and the LOQ was low (0.91 ng L-1) it is surprising that it was not found 
in other samples. Either the detection of this compound was possible in the clean-
est samples due to reduced suppression and matrix effects, or errors in measure-
ment caused a false finding. It is important to mention, though, that albendazole-
sulfone was found in a concentration below the limit of quantification. That 
means, the quantification is not reliable. The occurrence of albendazole-sulfone 
was only discussed here since the peak was clearly visible in the chromatogram. 
For future studies it would be recommendable to test recoveries with more matrix 
samples. As described, drinking water from the tap was used in this study to in-
clude matrix effects, since drinking water already contains matrix compounds. 
However, in order to account for the various samples, other matrices should be 
included as well, for example to derive direct recovery values for river water.  
 
For the treated drinking water, compounds that were present at the DWTP showed 
the same concentration in the tap water sample. This shows that compounds do not 
undergo degradation in the water supply system, nor does contamination occur 
after the treatment.  
  
47 
 
6.3 Treatment efficiency and treatment alternatives 
Neither the full-scale treatment plant, nor the nanofiltration step in the pilot plant 
was able to successfully remove the target contaminants. This becomes clear when 
comparing the compounds that were still present in the intake water. All of the 5 
compounds that were detected in the intake water are still present in samples from 
the full-scale treatment plant and the nanofiltration step (without GAC). Only 
when coupling the nanofiltration technology to a GAC treatment, 2 compounds 
could be removed with “old” GAC (in use for 5 months), while all of them were 
<LOQ after being treated with “new” GAC (in use for 1 week). This shows that 
the pilot plant with nanomembrane technology alone had almost no impact on 
contaminant concentrations. Only when coupled to granular activated carbon 
(GAC), concentrations decreased; therefore the removal of the target compounds 
was therefore most likely only performed by the carbon treatment step. In the full-
scale treatment chain is also a carbon treatment included; however, it is exchanged 
less often and its performance might have been reduced at the time of sampling. 
 
The average contaminant removal in the full-scale treatment plant was 4%; the 
only compound reduced in concentration was metoprolol with a reduction of about 
40% (full-scale). The other compounds remained more or less unchanged (Figure 
23, Figure 24). Conventional drinking water treatment plants with a combination 
of flocculation, sedimentation and sand filtration mechanisms have already before 
been shown to be ineffective in the treatment of organic micropollutants (Sarkar et 
al., 2007).  
 
Nicotine appeared to increase strongly in the pilot plant. Since magnification of 
nicotine within the plant is unlikely, reduced matrix effects probably lead to a 
better detection of the target compound. The good removal efficiency of activated 
carbon for many pesticides, pharmaceuticals and other synthetic organic com-
pounds (SOC) has been attested by several other studies. However, GAC is no 
guarantee for the efficient removal of all SOCs (Ivančev-Tumbas, 2014). While 
some membrane filtration studies were effective in contaminant removal, there 
have been studies that confirm the low removal rates of the nanofiltration (without 
GAC) that were presented (Ivančev-Tumbas, 2014). It can be concluded that the 
membrane technology that is currently tested in the pilot plant is not an appropri-
ate option for a full-scale solution, since it has not successfully removed the con-
taminants in question. 
 
Other studies showed that pharmaceuticals are poorly removed from water during 
the drinking water treatment process by the means of sand filtration or flocculation 
with iron(III)-chloride. However, they were successfully removed with granular 
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activated carbon (GAC) or ozonation (POSEIDON, 2004; Ternes et al., 2002). 
One study revealed that four tested pharmaceuticals in water matrices could be 
removed by treatment with ozone (O3) or ozonation combined with hydrogen per-
oxide (H2O2). The removal of pharmaceuticals by ozonation was also shown by 
Rosal et al. (2010), where some personal care products remained in the water, but 
pharmaceuticals were removed successfully. It was also shown that UV radiation 
in combination with titanium dioxide (TiO2) or ozone (O3) and TiO2 is able to 
remove some pharmaceuticals from water (Benitez et al., 2011). However, it has 
to be remembered that during disinfection steps in drinking water treatment with 
oxidation reagents like chlorine, ozone, chloramine, etc., so-called disinfection by-
products (DBPs) can be formed that might have severe genotoxic or carcinogenic 
effects (Richardson and Ternes, 2014). One example presented in Richardson and 
Ternes, 2014, was the formation of toxic N-nitrosodimethylamine (NDMA) after 
the reaction of a fungicide with ozone. The treatment of PPCPs with chlorine dis-
infection is not as efficient and leads to unknown transformation products (PO-
SEIDON, 2004). 
 
Although no pesticides were found at quantifiable levels in this study, possible 
options to reduce pesticide loads in environmental water sources are outlined 
shortly here. Gerecke et al. (2002) indicated that proper handling of farming 
equipment can reduce pesticide input into the environment dramatically. Teaching 
and information programs will train farmers for proper pesticide management. 
Furthermore, regulations for pesticides in urban environments should be reviewed 
due to the adhering long-term effects. Sarkar et al. (2007) were able to remove 
isoproturon successfully with an approach based on powdered activated charcoal 
(PAC) sorption and consecutive nanofiltration. Ozonation is most likely able to 
remove pesticides as well, since the ozone molecule is able to react with a broad 
range of organic compounds (Rosal et al., 2010). Preoxidation with chlorine com-
bined with coagulation was a reliable method examined by Ormad et al. (2008) for 
pesticide removal from drinking water. Preoxidation with ozone (without com-
bined coagulation) was found to be successful for most pesticides as well, while a 
treatment with coagulation alone was least efficient. Lastly, preoxidation with 
ozone and subsequent treatment with activated carbon removed almost all pesti-
cides from the water (Ormad et al., 2008).  
 
Another approach than removing the contaminants in the drinking water treatment 
plant would be to prevent them from entering the environment in the first place, 
i.e., increasing the removal efficiency of the wastewater treatment plant (Benitez 
et al., 2011). Ozonation is common and repeatedly recommended in drinking wa-
ter treatment but can as well be applied in wastewater treatment, since it is able to 
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remove micropollutants (Rosal et al., 2010). For most PPCPs, only advanced tech-
nologies like ozonation or activated carbon lead to successful treatment. Sludge-
retention time is important for the biological degradation of PPCPs; increasing the 
duration of this time can be a measure to reduce PPCPs loads (POSEIDON, 2004). 
In a study of Schaar et al. (2010), contrast media (pharmaceuticals used in X-ray 
chromatography) could not successfully be removed from wastewater; however, 
most of the examined compounds were removed by ozonation.  
6.4 Risk quotient, human health hazards and mixture toxicity 
The study aimed at providing information about contaminant concentrations from 
source to tap. It is therefore of primary interest, which contaminants can be found 
in treated drinking water or tap water and also to investigate whether these pose a 
risk to human health. The calculation of risk quotients is a common measure 
(Cleuvers, 2005; Gabet-Giraud et al., 2014; van der Aa et al., 2013) for risk evalu-
ation of contaminants. The concentrations found in the drinking water samples 
were low and do not pose a risk to human health even when consumed on a daily 
basis. The risk quotients as well as the sum of risk quotients were far below 1, 
indicating that there is no direct hazard from the individual compounds. The same 
is valid for the concentrations in the most polluted sample (Downstream). Howev-
er, these calculations do not include mixture toxicity effects, nor do they include 
the various other compounds that might be present in the water samples. The ap-
plication of risk quotients for the assessment of risks for humans is common but 
questionable since the PNEC values were derived from tests with aquatic organ-
isms. Large insecurities can occur from the differences in exposure between hu-
mans and aquatic organisms. However, the risk quotients calculated are so low 
that no risks for humans are expected. 
 
The estimation of risk quotients with PNEC values has been criticized. On the one 
hand, the parameters established depend strongly on the quality and quantity of 
collected data for toxic effects of single compounds. Differences between field and 
lab conditions can hardly be accounted for. Huge variations in PNEC values for 
individual contaminants can be found in the literature. Furthermore, contaminants 
rarely occur as single contaminants in the environment. Rather, a mixture is pre-
sent and the PNEC value cannot account for mixture effects (Chèvre et al., 2006). 
Chèvre et al. (2006) suggest a model based on species sensitivity distributions 
(SSDs) to calculate risk quotients for pesticides, allowing for the inclusion of 
mixture effects. However, this approach is only valid for substances with similar 
modes of action and could not be applied to calculate effects that result from for 
example (theoretical) interactions between pharmaceuticals and pesticides. 
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The addition of concentrations can overestimate mixture toxicity but can be seen 
as a kind of realistic worst-case scenario, It was shown to be appropriate for haz-
ard assessment of defined chemical mixtures, but even more for compounds of 
which availability of information on toxicity or molecular mechanisms was re-
stricted (Backhaus et al., 2000). It should also be noted that even worse cases can 
exist because of the limitation of including target analytes only. 
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7 Conclusion and outlook 
The current study aimed at analyzing water samples for investigating the occur-
rence of a range of pesticides, pharmaceuticals and personal care products. Com-
pared to other studies, the range of compounds analyzed was quite narrow - there-
fore, only limited information about the contamination situation in surface water 
and drinking water from Uppsala can be drawn. However, the calibration solutions 
prepared for the analysis contained a number of other compounds. Therefore, a 
deeper analysis of the samples (including more compounds) is possible and will 
provide more information. 
 
The main findings of this study show that surface water in Uppsala is contaminat-
ed with low levels of pharmaceuticals and personal care products. Contaminants 
were found to remain present throughout the sampling sites. For most compounds, 
concentrations were lower before the river Fyris passed Uppsala (upstream). The 
main source of the targeted compounds was found to be the WWTP effluent. This 
was known prior to the study (Daneshvar, 2012); however, the tracking of contam-
inants of different groups from source to tap was not performed before in this area. 
After the effluent of the communal WWTP entered the stream (downstream), con-
centrations raised to levels of up to 38 ng L-1 (caffeine). In the downstream river 
water, concentrations were highest for almost all compounds, the only exception 
being atenolol. Concentrations decreased in the two lake samples (Lake Ekoln and 
Lake Görväln) due to dilution effects. Within the DWTP, concentrations remained 
stable and contaminants were not removed efficiently with the conventional treat-
ment techniques of flocculation, sand filtration, GAC and disinfection with UV 
light and chloramine. Out of a total of 17 contaminants analyzed, 6 could be found 
in drinking water (atenolol, caffeine, carbamazepine, cotinine, metoprolol, nico-
tine). The full-scale DWTP was neither able to remove these compounds effective-
ly, nor to reduce their concentrations. The pilot-scale DWTP currently tested was 
ineffective as well, unless coupled to an activated carbon treatment step. Without 
carbon treatment, 5 of the target analytes could be detected in treated water from 
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the pilot plant. When coupled to new GAC, all targeted compounds were removed 
successfully.  
 
The occurrence of contaminants in drinking water was a known issue, and it seems 
that the search for an appropriate and cost-effective treatment method for drinking 
water is not completed, since the tested nanofiltration technique performed unsat-
isfactorily. The use of GAC is effective but expensive, therefore alternatives are 
needed. It has to be emphasized, that with the current knowledge about these con-
taminations, hazards are neither expected for humans nor aquatic organisms. This 
was shown by calculating risk quotients for individual compounds based on PNEC 
values. The summarized RQ values (∑RQ) of the detected contaminants were 
0.016 for drinking water and 0.040 for the most polluted environmental sample, 
indicating that no hazard results from the examined water samples. 
 
For the compounds selected, the used analytical methods worked satisfactorily. 
One suggestion presented was the use of only one extraction cartridge while taking 
more repetitions per sampling point for the inclusion of variations in the dataset. 
As the method was developed for a broad compound range screening, future pro-
jects will shed light on possible contaminations with other compounds than those 
targeted for in the current study. It also has to be mentioned that the samples in 
this study were taken as grab samples, i.e. they only represent the contamination 
situation of a short time window. Hence it would also be interesting to see the 
results of future studies, for example with samples from different seasons than in 
the current study. 
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10 Appendix 
 
10.1 Appendix A 
Coordinates of sampling points and map of the sampling sites 
 
 
Table 12: Coordinates of sampling points. 
Sampling point Coordinates (Decimal Degrees; WGS84) 
Fyris Upstream 60.011027 17.717783 
Fyris Downstream 59.831660 17.661302 
Lake Ekoln 59.757547 17.638128 
Lake Görväln / DWTP 59.417038, 17.753173 
School 59.417694 17.791111 
Supermarket 59.726361 17.789361 
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Figure 25: Map with sampling points. Source: Google Maps.  
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10.2 Appendix B 
 
Table 13: List of compounds in the calibration solution; compounds examined in this study are 
highlighted. 
Pesticides:     
2,4-D 
Acetamiprid 
Aklonifen 
Alaklor 
Aldrin 
Alfa-cypermetrin 
Amidosulfuron 
Amisulbrom 
AMPA 
Atrazin 
Atrazindesetyl 
Atrazindesisopropyl 
Azoxystrobin 
Beta-cyflutrin 
BAM 
Benazolin 
Bentazon 
Bifenox 
Bifenox-syra 
Bitertanol 
Boskalid 
Cyanazin 
Cyazofamid 
Cybutryn 
Cyflufenamid 
Cyflutrin 
Cykloxidim 
Cyprodinil 
Cypermetrin 
Deltametrin 
Difenokonazol 
Diflufenikan 
Diklobenil 
Diklorprop 
Diklorvos 
Dikofol 
Dimetoat Diuron 
Endosulfan-alfa 
Endosulfan-beta 
Endosulfansulfat 
Epoxikonazol 
Esfenvalerat 
Etofumesat 
Fenitrotion 
Fenmedifam 
Fenpropidin 
Fenpropimorf 
Flamprop 
Florasulam 
Fluazinam 
Fludioxonil 
Flupyrsulfuronmetyl 
Fluroxipyr 
Flurprimidol 
Flurtamon 
Flusilazol 
Flutriafol 
Foramsulfuron 
Fuberidazol 
Glyfosat 
HCH-alfa 
HCH-beta 
HCH-delta 
HCH-gamma 
Heptaklor 
Heptaklorepoxid 
Hexaklorbensen 
Hexazinon 
Hexytiasox 
Imazalil 
Imidakloprid 
Iprodion  
Isoproturon 
Jodsulfuronmetyl 
Karbendazim 
Karbofuran 
Karfentrazonetyl 
Karfentrazonsyra 
Klomazon 
Klopyralid 
Klordan-alfa 
Klordan-gamma 
Klorfenvinfos 
Kloridazon 
Klorpyrifos 
Klotianidin 
Kvinmerak 
Lambda-cyhalotrin 
Linuron 
Mandipropamid 
MCPA 
Mekoprop 
Mesosulfuronmetyl 
Metabenztiazuron 
Metalaxyl 
Metamitron 
Metazaklor 
Metiokarb 
Metolaklor 
Metrafenon 
Metribuzin 
Metsulfuronmetyl 
Pendimetalin 
Penkonazol 
Permetrin  
Pikloram 
Pikoxystrobin 
Pirimikarb 
Prokloraz 
Propamokarb 
Propikonazol 
Propoxykarbazon 
Propyzamid 
Prosulfokarb 
Protiokonazol-destio 
Pyraklostrobin 
Pyroxsulam 
Quinoxyfen 
Rimsulfuron 
Siltiofam 
Simazin 
Spiroxamin 
Sulfosulfuron 
Taufluvalinat  
Terbutryn 
Terbutylazin 
Terbutylazindesetyl 
Tiakloprid 
Tiametoxam 
Tifensulfuronmetyl 
Tiofanatmetyl 
Tolklofosmetyl 
Tolylfluanid 
Tribenuronmetyl 
Trifloxystrobin 
Trifluralin 
Triflusulfuronmetyl 
Trinexapak-etyl 
Trinexapak-syra 
Tritikonazol 
Vinklozolin 
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Pharmaceuticals:   
Acetaminophen 
Amitryptiline 
Amlodipine 
Atorvastatin 
Bezafibrate 
Bicalutamide 
Budesonid 
Caffeine 
Candesartan 
Cetirizine 
Citalopram 
Climbazole 
Clopidogrel hydrogensulfat 
Desvenlafaxine 
Diazepam 
Diclofenac 
Diltiazem 
Enalapril maleate 
Ethylparaben 
Fluconazole 
Furosemide 
Hydrochlorothiazide 
Ibuprofen 
Irbesartan 
Ketoconazole 
Ketoprofen 
Lamotrigine 
Lidocaine 
Losartan 
Methylparaben 
Naproxen 
Oxazepam 
Propylparaben 
Ramipril 
Saccharin 
Sertraline 
Simvastatin 
Sucralose 
Tamoxifen 
Terbutaline 
Valsartan 
Venlafaxine 
Zolpidem tartrate 
 
 
Fecal source tracing:   
Albendazole sulfone 
Albendazole sulfoxide 
Atenolol 
Atrazine 
Bentazone 
Benzoylecgonine 
Bezafibrate 
Blankophor (DAS-2) 
Caffeine 
Carbamazepine 
Cotinine 
Creatinine 
Cyanazine 
Diclofenac 
Fenbendazole-sulfon 
Fenylbutazon 
Flubendazole  
Flubendazole, 2-amine 
Fluorescent brightener 71 (DAS-1) 
Gemfibrozil 
Ibuprofen 
Isoproturon 
Ivermektin 
Ketoprofen 
Meloxicam 
Metoprolol 
Monensin 
Narasin 
Naproxen 
Nicotine 
Paraxanthine 
Quinmerac 
Simazine 
Toltrazuril 
Toltrazuril-sulfone 
Triclosan 
Vedaprofen 
Nandrolone (17b) 
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PFAA:   
PFBA (perfluorobutanoic acid) 
PFBS (perfluorobutane sulfonic acid) 
PFDA (perfluorodecanoic acid) 
PFDoDA (perfluorododecanoic acid) 
PFHpA (perfluoroheptanoic acid) 
PFHxA (perfluorohexanoic acid) 
PFHxS (perfluorohexane sulfonic acid) 
PFNA (perfluorononanoic acid) 
PFOA (perfluorooctanoic acid) 
PFOS (perfluorooctane sulfonic acid) 
PFPeA (perfluoropentanoic acid) 
PFUnDA (perfluoroundecanoic acid) 
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10.3 Appendix C 
Extraction efficiencies and recoveries - graphical presentation 
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Figure 26: Extraction efficiency of HLB and ENV cartridges. 
Figure 27: Recoveries of HLB and ENV cartridges. 
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10.4 Appendix D 
 
 
List of chemicals and devices used in the lab: 
 
Pop-Cans  Sharpsville Container; NSF Component; max capaci-
ty 3 gal. P/N 29748PS; Year 2013 
Pump  Masterflex L/S; Cole Parmer; model 7528-10; 6-600 
RPM 
Pumping module Masterflex easy-load 3; model 77800-62 
Tubings  Masterflex Norprene 06404-15; Mfg by Saint-
Gobain 
Filter station  Millipore Corporation; Bedford, Masssachusetts, 
U.S.A 01730;  Filter Diameter 142 mm 
Glassfiber Filters Whatman, GE Healthcare Life Sciences; Glass Mi-
crofibre Filters; GF/F; Diameter 142mm; 25 circles; 
Cat no. 1825-142; GE Healthcare UK Unlimited, 
Amersham Place Little Chalfont; Buckinghamsihre 
HP7 9NA, UK 
Glass bottles  VWR Borosilicate 3.3; 5000 mL; 215-2330 
SPE station  Waters, Milford, Massachusetts U.S.A;  
SPE HLB  Waters; Oasis HLB 200cc; 1g; LP Extraction Car-
tridge; Part-no. 186000117; sorbent batch no. 101A 
SPE ENV  Bond-Elut ENV; 1000mg; 6 mL; 30/PK. Agilent 
Technologies; Part No 12255012  
SPE reservoir  BondElut; Reservoir - 2 Frits; 20 ml capacity; 
100/PK. Part no. 12131017; Agilent Technologies 
Methanol 99%  LiChrosol hypergrade for LC-MS; Methanol,; Merck 
KGaA, 64271  Darmstadt, Germany; Purity > 99.9% 
Ethanol 99%  AnalaR NORMAPUR; Ethanol absolute; VWR 
Chemicals; VWR International, 201 rue Carnot, 
94126 Fontenay sous Bois, France; Product 
20821.310; Batch 13E170515 
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Ultrapure water EMD Millipore Corporation Milli-Q water 
Pipettes  VWR Ultra High Performance (100-1000 µl)
  VWR Ergonomic High Performance (1-10 ml) 
Pipette tips  VWR 
N-Evaporator  Organomation Associates Inc. 266 River Road West  
Berlin, MA 01503 U.S.A; model N-Evap 112 Nitrogen Evaporator 
Vials  Agilent Technologies, Vial, screw, 2ml; part no. 
5182-0716 
Vial caps  Agilent Technologies, Cap, 9mm, blue screw, part 
no. 5182-0717 
Falcon tubes  Corning Incorporated, Corning, NY, 14831; 50ml 
Centrifuge Tube (sterile) part no. 430290 
Centrifuge  Eppendorf Centrifuge 5810 
pH Indicator paper Macherey-Nagel GmbH & Co. KG; Neumann-
Neander-Str. 6-8, 52355 Düren, Germany; Special 
Indicator paper; 90211; 90213; 90207 
pH indicator sticks VWR Prolabo; Paper dosatest; code 35 311.604; 
VWR International, 201 rue Carnot, 94126 Fontenay 
sous Bois, France 
Sonicator  Branson 5510 
LC-MS  Xevo G2–S QTOF 
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10.5 Appendix E 
 
List of compounds added in internal standard mix: 
 
Fecal source tracing: 
D3-benzoylecgonine 
D7-atenolol 
D10-fenylbutazon 
D3-17b-nortestosteron 
13C6-diclofenac 
D3-meloxicam 
D3-paracetamol 
D3-ABZ-SO 
D3-ABZ-SO2 
D6-Cholesterol 
D3-toltrazuril sulfon 
D6-Bentazon 
 
 
PFAA: 
13C8 FOSA 
d3-N-MeFOSAA 
d5-N-EtFOSAA 
d3-N-MeFOSA 
d5-N-EtFOSA 
d7-N-MeFOSE 
d9-N-EtFOSE 
13C4 PFBA 
13C2 PFHxA 
13C4 PFOA 
13C5 PFNA 
13C2 PFDA 
13C2 PFUnDA 
13C2 PFDoDA 
18O2 PFHxS 
13C4 PFOS 
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10.6 Appendix F 
  
 
